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Apolipoprotein E gene polymorphism in Indian patients
with Alzheimer’s disease and vascular dementia
M. Tripathi, K. Luthra, A. B. Dey and R. Grover
Department of Neurology, All India Institute of Medical Sciences,
New Delhi, India
The association of apolipoprotein E gene polymorphisms with Alzheimer’s
disease and vascular dementia has been reported in several populations
including one from a rural community in North India. However, the
association of Apo E polymorphism with VaD is yet to be established in this
population.
Material and methods: In a case–control study involving 54 cases of
dementia (AD-29 and VaD-25) and 76 age matched healthy controls blood
was analysed for the Apoe polymorphism.
Results: The frequency of e4 allele was signiﬁcantly higher among cases of
AD and VaD compared with controls (p < 0.001). The e3e3 (p < 0.05) and
e3d3 (p < 0.001) genotypes were found to be protective. The odds of
developing AD or VaD were at 4.4 and 3.7 times higher respectively in
presence of even a single even e4 allele.
Results: Our results suggests that the increased risk of developing AD or
VaD is similar among Asian Indians in presence of apo e4 compared with
Caucasian population.
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Amyloid beta peptides and apoE4 decrease
phosphoinositides kinases activity in rat brain synaptic
plasma membranes
A. Zambrzycka and J. B. Strosznajder
Department of Cellular Signaling Medical Research Centre,
Warsaw, Poland
Phosphatidylinositol 4-kinase (PI4K), phosphatidylinositol 3-kinase (PI3K)
and phosphatidylinositolmonophosphate 5-kinase (PIP5K) that synthesize
polyphosphoinositides (PI, PIP, PIP2) are involved in intracellular signal
transduction, cytoskeletal function and neuronal survival. It was indicated
that PI4K and PI3K activity is decreased in the brain of patients with
Alzheimer’s disease (AD). However, the mechanism of inhibition is still
unclear. As amyloid beta peptides (Ab) in aggregated form are neurotoxic
and apolipoprotein E4 (apoE4) accelerates their aggregation, we examined
whether Ab 1-42 and apoE4 may be responsible for the inhibition of
phosphoinositides kinases activity. The aim of study was to investigate the
effect of Ab and apoE4 on these enzymes activity in cortical and
hippocampal synaptic plasma membranes (SPM) with endogenous and
exogenous inositolphospholipids and (c32P)ATP. The results indicated that
Ab is responsible for the lower phosphorylation of endogenous PIP to PIP2
in the brain cortex and hippocampus. This peptide and apoE4 decreased
PI4K activity in the brain cortex by about 20 and 40% respectively.
Preliminary data with wortmannin suggested that Ab and apoE4 affected also
PI3K. Moreover, apoE4 decreased PIP5K activity by 20% and Ab has no
effect on this enzyme. Arachidonic acid (AA) that is liberated by Ab
decreased phosphoinositides kinases activity. In conclusion, these studies
suggest that inhibition of phosphoinositides kinases activity by Ab and
apoE4 might by responsible for the alteration of cytoskeleton dynamic and
phosphoinositides signaling.
Keywords: Alzheimer’s disease, amyloid, apolipoproteins, brain,
phospholipids.
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Haloperidol stabilizes calcium-imbalance in Alzheimer’s
disease
A. Palotas, J. Kalman, M. Palotas, Z. Janka and B. Penke
Department of Medical Chemistry, University of Szeged, Szeged,
Hungary
Deposition of beta-amyloid peptide is the diagnostic neuropathologic feature
of Alzheimer’s disease. One of the underlying pathomechanisms of beta-
amyloid-induced cellular toxicity, based on the channel hypothesis, is the
disruption of the intracellular calcium homeostasis of neurons, ﬁbroblasts
and lymphocytes. Piling evidence demonstrates a low frequency of
Alzheimer’s disease in patients with schizophrenia, and it has been proposed
that antipsychotic medications, such as haloperidol, may be responsible.
Haloperidol has been recently reported to be a calcium and calmodulin
antagonist. Therefore we evaluated haloperidol for its effects on beta-
amyloid-induced calcium-imbalance on readily available tissues, such as
ﬁbroblasts. Basal intracellular calcium-level was measured in Fura-2AM-
loaded human ﬁbroblasts by dual wavelength spectroﬂuorimetry. Alzheimer
cells exhibited lower calcium-level when compared with the control cultures.
Exposure of ﬁbroblasts to beta-amyloid peptide resulted in increased calcium
concentration of the control cells, but not of Alzheimer ﬁbroblasts.
Preincubation of control cultures with haloperidol blocked the beta-
amyloid-induced elevation of calcium. This ﬁnding indicates that haloperidol
efﬁciently attenuates ionic imbalance and suggests that it may serve as a
potential agent in alleviating neurotoxic effects of beta-amyloid peptide.
Also, haloperidol may be a useful lead in the development of an effective
Alzheimer therapeutic agent.
Keywords: Alzheimer’s disease, amyloid, calcium, haloperidol.
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Prion protein ubiquitination and proteasomal
dysfunction in scrapie infection
B. S. Wong,* M. Whiteman, J. Sassoon, S. C. Kang,* R. Li,*
T. Pan,* M. A. Smith,* G. Perry,* D. R. Brown, T. Wisniewski§
and M. S. Sy*
*Institute of Pathology, Case Western Reserve University,
Cleveland, Ohio, USA; Department of Biochemistry, National
University of Singapore, Singapore; Department of Biology and
Biochemistry, Bath University, Bath, UK; §Department of
Neurology and Pathology, New York University, New York, USA
Although the key event in the pathology of prion diseases is believed to
involve the conversion of cellular prion protein (PrPC) to the partial protease-
resistant scrapie species termed PrPSc, the contributing factors to neurode-
generation in scrapie-infected animal are poorly understood. Accumulation
of PrPSc in infected brains can overwhelm the ubiquitin-proteasome systems,
which are important in maintaining cellular homeostasis. We found that in
mouse brains infected with the ME7 scrapie strain, there is an increase in
DNA breakage and a reduction in two endopeptidase activities associated
with proteasome function. In addition, the decline of proteasome activity was
accompanied by an elevation in the levels of total ubiquitin adducts. By using
a capture-ELISA, we found that the PrP species from infected brains are
ubiquitinated. These results suggest that increased DNA damage, impaired
proteasome function and ubiquitination of the PrP species may play a pivotal
role in the pathogenesis of prion diseases. Also, the ability to detect
ubiquitinated PrP species in affected brains may serve as a potential marker
for prion disease.
Keywords: neurodegeneration, oxidative stress, prion, scrapie, ubiquitin.
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Cyclohexylbisphenol inhibits oxidative stress in 1-
methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)
mouse model of Parkinson’s
M. Chalimoniuk,* Y. Liu, D. Kopczuk* and J. Strosznajder*
*Medical Research Centre, Polish Academy of Sciences, Warsaw,
Poland; The Salk Institute for Biological Studies, La Jolla, CA,
USA
The mechanism of neuronal degeneration in Parkinson’s Disease (PD) is up till
now unknown. The previous studies suggest that the free radicals are involved in
neuronal death in substantia nigra. Excessive synthesis of NO and cGMP altar
physiological and biochemical processes in cells. The aim of our studies was to
investigate effect of cyclohexylbisphenol (CHBP) on oxidative stress and cGMP
level in MPTP animal’s PD. Mice C57/BL received i.p. three injection of MPTP in
saline at 3-h intervals in total dose of 40 mg/kg b.w. Control mice were injected
saline only. After last injection of MPTP the same group of animals received one
injection of CHBP i.p. in a dose of 40 mg/kg b.w. Mice were killed after 3, 7 and
14 days. The striatum, midbrain, hippocampus and brain cortex were isolated. Free
radicals were assayed using ﬂuorescence method (DCF), lipid peroxidation was
evaluated by determination of thiobarbituric acid (TBARS). Moreover, cGMP and
glutathione level were estimated using ELISA and spectrophotometric methods.
Our results indicated that MPTP induced increase of oxidative stress (DCF,
TBARS), cGMP level and depletion of glutathione in striatum and midbrain 3, 7
and 14 days after injection. CHBP, which express to have a strong antioxidant
properties in vitro, also inhibited free radicals formation, lipid peroxidation and
protected glutathione level against depletion in MPTP animal_fs PD. CHBP had
no effect on MPTP induced elevation of cGMP in striatum and midbrain. These
results suggest that CHBP can be useful in treatment of PD.
Keywords: anioxidant, cGMP, Parkinson’s diease, superoxide dismutases.
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Challenges and excitements in understanding of abeta
peptides and aluminium induced helical transitions in
supercoiled DNA and POL
S. Anitha and K. S. Jagannatha Rao
Central Food Technological Research Institute, Mysore, India
We have ﬁrst time evidenced a Ba`Z conformational change in Alzheimer’s brain
genomic DNA in hippocampus. This ﬁnding lead to a hypothesis that Alzheimer’s
disease (AD) etiological factors like Aluminium (Al), amyloid beta peptide, Tau
etc., might play role in modulating DNA topology (1). We further observed that
Abeta and Al are localized in the nuclei in AD brain. This data gave impetus for
the present study of Al and Abeta interaction with DNA. Spectroscopic studies
have revealed that Abeta (1–42) could induce B a` Psi conformational change in
Supercoiled DNA (scDNA), Abeta (1–16) caused an altered B-form, while Al
induced a complex B-C-A mixed conformation. Al induced Z-DNA in poly (GC)
while showed strong binding to poly (AT). Abeta peptides (1–16, 1–28 & 1–40)
induced A-DNA conformation in poly (AT), with no helicity change in poly (GC).
Ethidium bromide binding and agarose gel studies revealed that Al linearized the
sc DNAwhile Abeta (1–42) and Abeta (1–16) caused partial linearization and also
showed differential sensitivity to Chloroquine towards topoisomers separation.
This is the ﬁrst report to show that Abeta and Al modulate helicity in scDNA, poly
(AT) and poly (GC). This information may throw a new light in understanding
molecular biology of Alzheimer’s disease.
Keywords: Abeta, aluminium, Alzheimer’s Disease, DNA, Z-DNA.
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Aluminium amino acid complexes interaction with
supercoiled DNA: a new evidence on DNA helicity change
in relevance to Alzheimer’s
D. Bharathi and K. S. Jagannatha Rao
Central Food Technological Research Institute, Mysore, India
Alzheimer’s disesase (AD) is a complex neurological disorder with multiple
etiology. In AD brain, racemized forms of amino acids in particular, D-Aspartate
and D-Glutamate are relatively in large proportions in amyloid plaques and neuro-
ﬁbrillary tangles. Reports from our lab revealed that Aluminium (Al), an
etiological factor of AD, favors stereoinvertion from L to D enantiomer in aged
rabbit brain. Al,as Al-aminoacid complexes were able to cross the blood–brain
barrier and deposit in the brain. Further, the observation that Al and Abeta(rich in
D-Asp and D-Glu) are localized in the nuclei, provides an insight for the present
study of Al-amino acid complexes interaction with DNA. Thereby L and D forms
of Al-Aspartate and Al-Glutamate interaction with DNA could contribute to DNA
conformational change. Circular Dichroism studies of Al-D-Asp interaction with
supercoiled DNA revealed B to C DNA conformational change, while Al-L-Asp,
Al-L-Glu & Al-D-Glu complexes showed strong binding to DNA. EDTA could
reverse DNA conformation from C-B whereas desferoximine could not.
Interstingly C-DNA induced by Al-D-Asp was treated with spermine elevated in
AD, further induced an asymmetric condensation of limit C-motif to a psi-DNA.
The results are also supported by Gel studies, EtBr binding pattern. The spacial
arrangement of molecules were understood by carrying out computer modeling
studies. The differential DNA binding property of Al-amino acid complexes is
dictated by the stereoisomerism and chirality of the complexes. This is the ﬁrst
study which provides a novel understanding on the role of Al-D-Asp modulating
DNA conformations relevance to AD.
Keywords: Aluminium-D-Aspartate, Alzheimer’s disease, C-DNA, psi-DNA,
spermine.
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Modeling of trace elemental inter-relationships in serum
samples of neuro-degenerative (Alzheimer’s, Parkinson’s
diseases) and neu
P. Shanmugavelu, T. S. Sathyanarayana Rao, M. L. Hegde,
M. S. Mushtaque, D. Bharathi, S. Anitha, R. B. Menon, R. V. Rao
and K. S. Jagannatha Rao
Department of Biochemistry and Nutrition, Central Food
Technological Research Institute, Mysore, India
The data on trace elements in different vital organs in normal and pathological
conditions is very essential to establish a cause and effect relationship. Analysis of
trace level elements were carried out using Inductively Coupled Plasma Atomic
Emission Spectrometry (ICPAES) in brain and CSF of Alzheimer’s disease (AD),
and serums of Parkinson’s disease (PD) and Bipolar disorder (BPD). The results
indicated a deﬁnite pattern of inter-elemental relationships. In moderately affected
AD brains, monovalent elements were signiﬁcantly reduced, while divalent
elements were increased compared with normal brain. In severely affected AD
brains, Al, S, Fe were predominantly present displacing other elements. It was
found that Zn and Fe accumulate more in moderate, while Fe and Al deposition
was more in severely affected AD. In severely affected AD brain regions, trivalent
elements (Al and Fe) were predominantly present over monovalent and divalent
elements compared with normal brain. In case of CSF samples, Al, Mg, Mn and
Ca levels did not show any signiﬁcant change between normal and AD CSF.
However, K, P, and S were (p < 0.0001) decreased signiﬁcantly, while Na level
was (p < 0.0001) increased in AD CSF. Trace elements of serum in PD and BPD
clearly showed a signiﬁcant change for few elements in comparison with control.
The observations are novel and signiﬁcant. A comprehensive database was
developed to inter-relate serum, CSF and brain on normal, PD, AD and BPD. Also
the role of trace elemental homeostasis in neuro-degenerative and neuro-
psychiatric disorders was hypothesized.
Keywords: inter-realtionships, modeling, neurodegenerative disorders, neuro-
psychistry disorders, trace metals.
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Impairment of signal pathway for neuronal survival in
hippocampus of Alzheimer’s disease
S. Shuli, M. Yan and J. Zhijuan
Beijing Research Laboratory for Brain Aging, Xuanwu Hospital,
Capital University of Medical Sciences, Beijing, China
The neuronal loss is one of AD neuropathological characteristic but the
mechanism is still not well understand. In order to probe into the cause of
neuronal loss, we observed the expression change of several proteins related
to the signal transduction pathway for neuronal survival and apoptotic
cascade for neuronal death in the AD (six cases) and non-AD (ﬁve cases)
hippocampus. By application of immunohistochemistry and immunoprecip-
itation-Western blot, we found that Tunel positive cell in AD was one time
more than in the non-AD control on basis of the neuron number. The
expression of Akt/PKB, CREB (c-AMP response element binding protein),
p-CREB (phosphorylated CREB) and Bcl-2 in AD were diminished. AIF
(apoptosis-inducing factor) expression was increased. But Bax expression
was not change. The ratio of Bcl-2 and AIF in AD was 0.47, but in non-AD
was 0.99. It appears that AIF increase is very important. Our preliminary date
suggest that neuronal survival signal pathway was impaired. It is possible to
lead neuronal apoptotic cascade and neuronal loss.
Key words: Alzheimer’s disease, hippocampus, neuronal survival, signal
pathway.
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Aluminium amino acid complexes interaction with
supercoiled DNA: a new evidence on DNA helicity
change in relevance to Alzheimer’s
D. Bharathi and K. S. Jagannatha Rao
Biochemistry and Nutrition Department, Central Food
Technological Research Institute, Mysore, India
Alzheimer’s disease (AD), a complex neurological disorder with multiple
etiology. In AD brain, racemized forms of amino acids in particular, D-Asp
and D-Glu are relatively high in Abeta neuro-ﬁbrillary tangles. Reports from
our lab revealed that Aluminium (Al), an etiological factor of AD, favors
stereoinvertion from L to D enantiomer in aged rabbit brain. Al in the form of
Al-amino acid complexes were able to cross the blood–brain barrier and
deposit in the brain. Further, the observation that Al & Abeta(D-Asp) are
localized in the chromatin region of the nuclei, provides an insight for the
present study of Al-amino acid complexes interaction with DNA. Circular
Dichroism studies of Al-D-Asp interaction with supercoiled DNA revealed
B-C conformational change, while Al-L-Asp, Al-L-Glu & Al-D-Glu
complexes showed strong binding to DNA. EDTA could reverse DNA
conformation from C-B whereas desferoximine could not. Interestingly C-
DNA induced by Al-D-Asp treated with spermine (elevated in AD)
transformed the limit C-motif into asymmetrically condensed chiral Psi-
DNA. Gel studies indicated that Al amino acid complexes did not affect the
supercoiling of DNA. Only Al-D-Asp-DNA complex showed sensitivity
towards Chloroquine induced topoisomers separation. The differential DNA
binding property of Al-amino acid complexes is dictated by the stereo’s and
chirality of the complexes. This is the ﬁrst study which explores newer
understanding on the role of Al-D-Asp modulating DNA conformation in the
pathogenesis of AD.
Key words: Al-D-Asp, Alzheimer’s disease, C-DNA, psi-DNA, spermine.
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Morphological and molecular tau pathology in the white
matter of Alzheimer-type dementia
K. Ikeda, T. Arai, H. Akiyama and S. Iritani
Department of Psychogeriatrics, Tokyo Institute of Psychiatry;
Department of Psychiatry, Tokyo Metropolitan Matsuzawa
Hospital, Tokyo, Japan
White matter changes in ATD are a matter of argument. Secondary axonal
degeneration and/or vascular change are assumed to their origin. We
investigated whether there were primary tau pathology in the cerebral white
matter using following methods. Tissues obtained from six patient of ATD at
autopsy are ﬁxed in 70%-ethanol in 150 mM NaCl or 4%-PFA in 0.1 M
phosphate buffer. Sections were immunostained by 14 kinds of tau
antibodies, which recognize various epitopes of tau. Immunoelectron
microscopy was also performed. Ethanol ﬁxed sections revealed massive
tau-positive thread-like structures in the white matter, which scarcely
observed in 4%-PFA ﬁxed sections. Antibodies recognizing repeat-region
(core part of tau) could not reveal these thread-like structures. On
immunoelectron microscopy, these threads coincided with axons. Occasion-
ally amorphous structures among ﬁbrillar solid structures were immunola-
belled. There were extensive axonal degeneration in the white matter of
ATD. Immunoblotting revealed that the ratio of full-length tau is high in the
white matter compared with gray matter. Deposited axonal tau in the white
matter, differed from NFT or NT, seems not to undergo excessive processing.
Key words: Alzheimer-type dementia, pathology, tau, white matter.
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Enhanced expression of the P2X4 receptor in duchenne
muscular dystrophy correlates with macrophage
invasion
D. C. Gorecki,* D. Yeung,* R. Kharidia* and S. Brown
*Institute of Biomedical and Biomolecular Sciences, School of
Pharmacy and Biomedical Sciences, Portsmouth; Dubowitz
Neuromuscular Unit, Department of Paediatrics, Imperial College,
Hammersmith Campus, London, UK
Following molecular and immunohistochemical analysis of the purinergic
P2X4 receptor in dystrophin-deﬁcient muscle we have identiﬁed a distinct
subpopulation of P2X4-positive cells inﬁltrating the dystrophic ﬁbres. These
cells were absent from normal muscle and rarely present in the dystrophic
muscle taken before and after the onset of degeneration. We have identiﬁed
these P2X4-positive cells as macrophages, demonstrating for the ﬁrst time
that human and mouse macrophages express P2X4 in addition to P2X7
receptors both in vitro and in situ, in speciﬁc tissues. Moreover, we
demonstrated that the increase in the P2X4 expression is yet another feature
of an inﬂammatory response identiﬁed in DNA arrays of dystrophic muscle.
Immunohistochemical analysis failed to detect any expression of P2X4
protein in adult skeletal or cardiac muscle ﬁbres, while myoblasts in culture
expressed this receptor, as detected by RT-PCR and western blotting. This
indicates developmental regulation of P2X4 expression in muscle. In the
light of a signiﬁcant role played by macrophages in the dystrophic process,
the function of P2X receptors and their role in the Duchenne pathology as
well as their potential role in therapeutic applications will be discussed.
Keywords: ATP, Duchenne muscular dystrophy, inﬂammation, macrophage,
purinergic receptors.
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Dephosphorylation of microtubule-associated protein
tau by protein phosphatase 5
C.-X. Gong,* F. Liu,* G. Wu,* S. Rossie, J. Wegiel,* L. Li,*
I. Grundke-Iqbal* and K. Iqbal*
*New York State Institute for Basic Research in Developmental
Disabilities, Staten Island; Purdue University, West Lafayette, USA
Protein phosphatase (PP) 5 is a 58-kDa novel phosphoseryl/phosphothreonyl
protein phosphatase. It is ubiquitously expressed in all mammalian tissues
examined, with a high level in the brain, but little is known about its
physiological substrates. We found that this phosphatase dephosphorylated
recombinant tau phosphorylated with cAMP-dependent protein kinase and
glycogen synthase kinase-3b, as well as abnormally hyperphosphorylated tau
isolated from brains of patients with Alzheimer’s disease. The speciﬁc
activity of PP5 toward tau was higher than or comparable with those reported
with other protein substrates examined to date. The PP5 activity toward tau
was stimulated by arachidonic acid by 30–45-fold. Immunostaining
demonstrated that PP5 was primarily cytoplasmic in PC12 cells and in
neurons of postmortem human brain tissue. A small pool of PP5 associated
with microtubules. Transfection of various PP5 plasmids into PC12 cells
revealed that PP5 dephosphorylated tau in these cells. These results suggest
that PP5 plays a role in the dephosphorylation of tau and thus can be
involved in the molecular pathogenesis of Alzheimer’s disease.
Keywords: Alzheimer’s disease, dephosphorylation, protein phosphatase 5,
tau protein.
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Impairments of cholinergic and noncholinergic
neurotransmission in transgenic Tg2576 mouse brain
with Alzheimer-like pathology
M. Klingner,* J. Apelt,* D. Sorger, O. Sabri, J. Steinbach,
M. Scheunemann and R. Schliebs*
*Paul Flechsig Institute for Brain Research; Department of
Nuclearmedicine and Institute of Interdisciplinary Isotope
Research, University of Leipzig, Leipzig, Germany
The cortical cholinergic deﬁcits observed in brains from Alzheimer patients
are highly correlated with the extent of neuropathological changes. To
address the question whether beta-amyloid may contribute to these deﬁcits,
brain tissue from transgenic Tg2576 mice with Alzheimer plaque pathology
at ages of 5 (still no signiﬁcant plaque load) and 17 months (high cortical
plaque burden) were examined for a number of cholinergic and noncholin-
ergic markers. Transgenic mice with no signiﬁcant plaque load demonstrated
reduced hemicholinium (HC)-3 binding to choline uptake sites in anterior
brain regions as compared with nontransgenic littermates, while in aged
transgenic mice decreased HC-3 binding levels regionally correlated with
high plaque load. The beta-amyloid-associated decrease in high-afﬁnity
choline uptake sites in some cortical brain regions was accompanied by an
increase in vesicular acetylcholine transporter binding of vesamicol. Alpha1-,
alpha2- and beta-adrenoceptor binding levels were hardly affected in aged
transgenic mice. The data provide evidence of a modulatory role of beta-
amyloid on cortical cholinergic neurotransmission but with differential
actions on distinct cholinergic synaptic markers. The development of changes
in cholinergic synaptic markers in transgenic Tg2576 mouse brain already
before the onset of progressive plaque deposition provides in vivo evidence
of a modulatory role of soluble beta-amyloid on cholinergic neurotransmis-
sion and may be referred to the deﬁcits in learning and memory observed in
these mice also before signiﬁcant plaque load.
Keywords: acetylcholine, Alzheimer’s disease, choline uptake, neurotrans-
mission, receptor.
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Neuronal and glial expression of BACE1
S. Rossner, C. Lange-Dohna, G. von Geldern, U. Zeitschel,
M. Hartlage-Ru¨bsamen and V. Bigl
Paul Flechsig Institute for Brain Reseach, Leipzig, Germany
The beta-site amyloid precursor protein (APP)-cleaving enzyme (BACE1) is
a prerequisite for the generation of b-amyloid peptides, which give rise to b-
amyloid deposits in the brains of Alzheimer’s disease patients. It is believed
that BACE1 is exclusively expressed by neurons. However, here we show
that the BACE1 protein is also expressed by reactive astrocytes in proximity
to b-amyloid plaques of APP transgenic mice and in animal models of
chronic rather than acute gliosis. To identify elements which drive tissue- or
cell type-speciﬁc BACE1 expression we cloned a 1.5 kb fragment of the rat
BACE1 promoter and generated BACE1 promoter-luciferase reporter
constructs. The basal activity of this promoter construct was highest in
neuronal cell lines and in the pancreatic cell line AR42J, somewhat lower in
rat primary neurons, astrocytic and microglial cultures, very low in
hepatocytes and almost absent in ﬁbroblasts and in the monocyte-
macrophage cell line RAW264.7. Similar results were obtained in these
cells by RT-PCR and by immunocytochemistry to detect BACE1 mRNA and
protein, respectively. These data indicate that BACE1 is not a neuron-speciﬁc
enzyme. We conclude that brain glial cells, in particular astrocytes, may
contribute to increased generation of b-amyloid peptides and to accelerated
formation of b-amyloid plaques in the course of Alzheimer’s disease.
Keywords: aging, Alzheimer’s disease, gene expression, glial cells, neurons.
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Expression of b-secretase BACE is differentially
controlled through muscarinic acetylcholine receptor
signalling
T. Zuchner and R. Schliebs
Paul Flechsig Institute for Brain Research, Leipzig, Germany
b-Amyloid peptides, derived by proteolytic cleavage from a much larger
amyloid precursor protein (APP), play a major role in the pathogenesis of
Alzheimer’s disease by forming aggregated, ﬁbrillary complexes that have
been shown to be neurotoxic. Therefore, preventing b-amyloid formation by
inhibition of APP-processing secretases is considered as potential strategy to
treat Alzheimer’s disease. Recently, the transmembrane aspartyl protease b-
site APP-cleaving enzyme (BACE) has been identiﬁed as b-secretase. As
cholinergic mechanisms have been shown to control APP processing, the
present study intends to reveal whether the expression of BACE is
particularly driven by muscarinic acetylcholine receptor (mAChR) using
neuroblastoma cell line SH-SY5Y as a model. Stimulation of cells with the
M1- and M3-selective mAChR agonist talsaclidine for 1 h resulted in a dose-
dependent increase in BACE expression up to 2.5-fold over basal level,
detectable 24 h following stimulation. Similar effects of BACE upregulation
were observed, when protein kinase C (PKC) was directly activated by
phorbol esters. In contrast, BACE expression is suppressed below the basal
level by stimulating M2-mediated pathways by both selective M2-agonist
binding or by direct activating of adenylate cyclase with forskolin. The data
indicate that BACE expression is differentially controlled by mAChR
signalling: agonist binding to M1/M3-mAChR and stimulation of PKC
upregulates BACE expression, while BACE expression is downregulated
through activation of M2/M4-mAChR and protein kinase A-mediated
pathways. The data suggest that selective inhibition of brain M1/M3-
mAChR signalling should be potential to suppress excessive b-amyloid
formation in Alzheimer’s disease.
Keywords: Alzheimer’s disease, amyloid, BACE, muscarinic receptor,
signal transduction.
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Interaction of interleukin-1b with muscarinic
acetylcholine receptor-stimulated signaling cascade in
cell culture
M. Gniezdzinska,* L. Kirazov, A. Szutowicz and R. Schliebs*
*Paul Flechsig Institute for Brain Research, University of Leipzig,
Germany; Institute of Experimental Morphology & Anthropology,
Bulgarian Academy of Sciences, Soﬁa, Bulgaria; Clinical
Biochemistry, Department of Laboratory Medicine, Medical
University of Gdansk, Poland
b-Amyloid plaque-mediated glial upregulation of the pro-inﬂammatory cytokine
interleukin-1b (IL-1b) has been assumed to contribute to the impairments of
cortical cholinergic neurotransmission observed in Alzheimer’s disease. To test for
this hypothesis, a murine cholinergic septal cell line SN56 was exposed to IL-1b
followed by agonist stimulation of muscarinic acetylcholine receptors (mAChR)
and detecting key molecules of both signaling cascades. The activities of
acetylcholinesterase (AChE) and choline acetyltransferase (ChAT) of SN56 cells
were dose-dependently increased following stimulation with carbachol, while
stimulation of cells with the M1-mAChR-speciﬁc agonist talsaclidine did not
affect cholinergic enzyme activities, suggesting that the carbachol-induced
increases in cholinergic enzyme activities are mainly mediated through M2-
mAChR signaling. Pre-exposure of SN56 cells to IL-1b (1ng/mL) for 1 h did not
affect the carbachol-stimulated formation of inositol phosphates, but signiﬁcantly
induced the expression of ChAT mRNA and AChE activity while ChAT activity
was not affected by IL-1b. Stimulation of IL-1b-pre-exposed cells with carbachol
resulted also into upregulation of AChE activity and ChAT mRNA but to a lower
extent as compared with incubations in the absence of carbachol, indicating
interactive mechanisms between IL-1b and mAChR signaling cascades which may
contribute to the cholinergic deﬁcits in Alzheimer’s disease.
Keywords: acetylcholine receptor, acetylcholinesterase, cell culture, choline
acetyltransferase, interleukins.
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Involvement of PKR in mediating the activation of
caspases in b-amyloid peptide neurotoxicity
K. C. Suen, M. S. Yu, J. Hugon, K. F. So and R. C. C. Chang
Department of Anatomy, Central Laboratory of the Institute of
Molecular Technology for Drug Discovery and Synthesis, The
University of Hong Kong, Hong Kong
b-Amyloid peptide (Ab) has been considered to play an important role in the
pathogenesis of Alzheimer’s disease (AD). Ab has been shown to induce neuronal
apoptosis. Cysteine-dependent aspartate-speciﬁc proteases (caspases) are a crucial
mediator in apoptosis. Among 14 known caspases, caspase-1, -2, -3, -6, -8, -9 and
-12 have been found to be involved in Ab-induced neuronal apoptosis. PKR, a
double-stranded RNA-dependent serine/threonine protein kinase has been reported
to be signiﬁcantly involved in apoptosis. Once activated, PKR phosphorylates
eukaryotic initiation factor 2 alpha (eIF2a), resulting in inhibition of global protein
synthesis. We have recently reported that PKR is activated in Ab-induced neuronal
death. Degenerating neurons in the brains of AD patients also displayed high
immunoreactivity of phosphorylated PKR and eIF2a. In addition to the inhibition
of global protein synthesis by phosphorylating eIF2a, PKR might have other roles
in mediating neuronal apoptosis induced by Ab. In the present study, we aim to
investigate whether PKR can mediate activation of caspases (caspase-2, -3, -8 and
-9) in neurons exposed to Ab. Our results showed that caspase-2, -3, -8 and -9
were less activated in primary cortical neurons from PKR-knockout mice than
those from wild-type mice when the neurons were treated with 25 lM of Ab for
16 h. This suggests that PKR might play a crucial role in regulating the activation
of caspases in Ab-induced apoptosis. We are now further studying how the
possible mechanisms underlying PKR-mediated activation of caspases in neuronal
apoptosis induced by Ab.
Keywords: amyloid, apoptosis, caspases, protein kinase, protein phosphorylation.
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PERK might not be involved in b-amyloid peptide-
induced endoplasmic reticulum stress in neurons
K. C. Suen, M. S. Yu, J. Hugon, K. F. So and R. C. C. Chang
Department of Anatomy, Central Laboratory of the Institute of
Molecular Technology for Drug Discovery and Synthesis, The
University of Hong Kong, Hong Kong
b-Amyloid peptide (Ab) has been proposed to play a signiﬁcant role in the
pathogenesis of Alzheimer’s disease. Endoplasmic Reticulum (ER) stress has been
suggested to be one of the mechanisms leading to Ab-induced neuronal cell death
as some of the ER stress-related markers including caspase-12, Grp78 and
Gadd153 were reported to be involved in Ab toxicity. PERK, a PKR-like kinase
has been suggested to be activated under ER stress. It phosphorylates eukaryotic
initiation factor 2 alpha, resulting in inhibition of global protein synthesis.
Involvement of PERK has been shown in many ER stress models such as DTT-
and thapsigargin-triggered ER stress. However, little is known about its roles in
Ab toxicity in neurons. In the present study, we investigate whether this kinase is
activated in neurons exposed to Ab. Our results showed that Ab can induce ER
stress in cultured cortical neurons in terms of up-regulation of GRP78 and
activation of caspase-7 which has recently been proposed to be associated with ER
stress. While Ab can induce ER stress in neurons, western-blotting analysis on
PERK showed that amino acid residue at threonine-980 was not phosphorylated in
Ab neurotoxicity. Yet, it is activated by other ER stress inducers such as DTT and
thapsigargin. This differential participation of PERK in ER stress in neurons
suggests that PERK might not be required in all types of ER stress such as Ab-
induced ER stress. Moreover, there might be some unknown signals which are
necessary for the activation of PERK but they are inhibited in Ab toxicity.
Keywords: amyloid, caspases, protein kinase, protein phosphorylation, stress.
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Reduction of intracellular calcium increase provides
partial protection against b-amyloid peptide
neurotoxicity
K. C. Suen, J. Hugon, K. F. So and R. C. C. Chang
Department of Anatomy, Central Laboratory of the Institute of
Molecular Technology for Drug Discovery and Synthesis, The
University of Hong Kong, Hong Kong
b-Amyloid peptide (Ab) has been proposed to play an important role in the
pathogenesis of Alzheimer’s disease. One of the proposed mechanisms of Ab
toxicity is the disturbance of intracellular calcium homeostasis. Ab can induce an
increase in intracellular calcium in neurons, probably due to inﬂux from
extracellular space or release from intracellular organelles such as endoplasmic
reticulum (ER). In this notion, depletion of calcium from the ER can further extend
the toxicity of calcium. Prolonged ER calcium depletion could trigger ER stress. In
the present study, we focus on whether modulation of intracellular calcium levels
or reduction of calcium release from the ER could provide neuroprotection against
Ab. Our results showed that neurons cultured in low-calcium medium were not
resistant to Ab toxicity, suggesting that extracellular calcium might not be the main
source of Ab toxicity. Then, we tried to focus on intracellular calcium release from
the ER. Our data demonstrated that three ER calcium release modulators,
2-aminoethoxydiphenyl borate, xestospongin C and FK506 attenuated Ab toxicity
evaluated by the release of LDH, quantiﬁcation of apoptotic nuclei, PARP
cleavage and caspase-3 activation. Yet, an intracellular calcium chelator, BAPTA-
AM could not reduce Ab-induced caspase-3 activation, indicating that simply
reduction of intracellular calcium might not be a good therapeutic strategy against
Ab toxicity. Interestingly, our data showed that the three ER calcium modulators
reduced up-regulation of GRP78 induced by Ab, suggesting the signiﬁcance of ER
stress in Ab toxicity.
Keywords: amyloid, apoptosis, calcium, caspases, stress.
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Expression and function of dual genes system of
tyrosine hydroxylase gene and aromatic L-amino acid
decarboxylase gene in vitro
H. Yang, Y. Su, C. Duan, C. Zhao, Q. Xu and H. Yang
Beijing Institute for Neuroscience, Beijing Center for Neural
Regeneration and Repair, Capital University of Medical Sciences,
Beijing, P.R.China
Objective: The characteristic pathological changes of Parkinson’s disease include
a severe loss of dopamine neurons in the substantia nigra and a severe decrease in
dopamine in the striatum. The enzymes of TH and AADC in the biosynthetic
pathway for dopamine were considered to be low. A promising approach to the
gene therapy of PD is augmentation of enzymes in the biosynthetic pathway for
dopamine.
Methods: Human TH and AADC genes were recombinded into retrovirous
vectors pLHCX and pLNCX2 respectively. Then pLHCX/TH and pLNCX2/
AADC were transfected into packaging cell line PA317 with liposome. The
PA317/TH and PA317/AADC were selected by antibiotics. Gene expression was
examined by methods of immunohistochemistry and in situ hybridization. The
catalytic activity of two-cloned enzyme genes was assessed in vitro by HPLC-EC.
Result: Immunohistochemistry staining showed that TH and AADC were
expressed efﬁciently in vitro. Both TH and AADC mRNA were transcripted in
PA317 cell lines by using in situ hybridazation. HPLC-EC experiments revealed
that transfected cells produced a signiﬁcantly higher level of dopamine and L-dopa
than untransfected cell, especially added cofactor. The two genetically modiﬁed
cells can improve L-dopa and dopamine in response to administered substrate.
Conclusion: The present results suggested that not only recombinant TH and
AADC genes were successfully expressed in vitro, but also the results of enzyme
activity assays indicated that they had functional activities respectively. These
results have set up a way for in vivo gene therapy of Parkinson’s disease with TH
and AADC genes.
Keywords: aromatic L-amino acid decarboxylase, gene therapy, Parkinson’s
disease, retrovirous vector, tyrosine hydroxylase.
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Axonal loss and a-synuclein expression in MOG-induced
chronic relapsing EAE in the rat
R. Reynolds and D. Papadopoulos
Department of Neuroinﬂammation, Division of Neuroscience,
Imperial College London, Charing Cross Campus, London, UK
The accumulation of axonal loss is one of the important contributors to progression
of disability in Multiple Sclerosis (MS) and is known to begin early in the disease.
Here we test the hypothesis that axonal loss determines permanent neurological
impairment in inﬂammatory demyelination. EAE was induced in adult female DA
rats by injection of mouse myelin oligodendrocyte glycoprotein (MOG) in IFA.
Animals were grouped into those that exhibited a chronic progressive disease
course and those that showed a chronic relapsing–remitting course. Demyelination,
axonal loss and inﬂammation were quantiﬁed at varying time points. In
progressive EAE, axon loss, demyelination and inﬂammation all correlated
signiﬁcantly with clinical severity scores. In the lateral and dorsal funiculi the
decrease in axon number, compared with controls, reached 64.5% by 40 days after
the ﬁrst symptoms. In the late chronic stage of relapsing–remitting EAE only
axonal loss correlated with clinical severity scores. Classiﬁcation of axons into
groups according to size showed that small caliber axons were preferentially lost in
both relapsing and progressive EAE. These results provide evidence that axonal
loss can determine irreversible neurological disability in inﬂammatory demyeli-
nated lesions of the spinal cord, similar to those seen in MS. Axons in MOG-
induced EAE lesions displayed both SMI-32 and APP immunoreactivity,
suggesting similar axonal changes to those seen in MS. Interestingly, a-synuclein
immunostaining, negligible in control CNS tissue, was greatly upregulated in
motoneurons, astrocytes and oligodendrocytes in areas of inﬂammation. In situ
hybridization conﬁrmed that there was an increase in a-synuclein mRNA levels in
motoneurons.
Keywords: axon degeneration, demyelination, EAE, inﬂammation, multiple
sclerosis.
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Nonapoptotic neurodegeneration in the cerebral cortex
of young adult wistar rats prenatally exposed to ethanol
F. A. Fakoya and E. A. Caxton-Martins
Department of Anatomy and Cell Biology, Faculty of Basic Medical
Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria
Apoptosis has been adduced as an important neurodegenerative mechanism
following prenatal ethanol exposure (PEE). This study investigated the hypothesis
that this effect of PEE persists into adulthood. Dated pregnant female adult wistar
rats were divided randomly into groups A and B (n ¼ 6) and C (n ¼ 4). Group A
received a daily ethanol dose of 5.8 g/Kg body weight/day, on the 9th, 10th, 11th,
and 12th day of gestation by intragastric intubations, at 16.00 hours (PEE); group
B was pair-fed with the ethanol dams and received an isocaloric solution of sucrose
to substitute for the ethanol in the experimental group, for the same duration (PF),
while group C received standard chow (Ladokun Feeds, Ibadan, Nigeria) (C) and
water ad libitum. The animals were allowed unto normal parturition. The
neocortexes of the adult offsprings were examined at 42 days of age using
immunohistochemical (TUNEL staining method for apoptosis) and neurohisto-
logical (Nissil, Luxol-Fast-Blue-Nissil and Bodian silver staining) techniques. The
microanatomy of the neocortex from the treatment group were distorted,
particularly the layer V pyramidal neurons, which consisted mostly of pyknotic
pyramidal neurons, with broken apical dendrites, collapsed cell bodies, obliterated
nuclei and nucleoli. Intracellular neuroﬁbrillary tangles were not observed. The
TUNEL reaction was negative in both groups. Apoptosis does not appear to play a
role in the mechanism of action occurring in this age group of animals; these
neurodegenerative changes possibly underlie the neurobehavioural deﬁcits that
have been variously described.
Keywords: apoptosis, cerebral cortex, neurodegeneration, prenatal ethanol
exposure, pyknosis.
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5-HTTPR is associated with altered neocortical
[3H]citalopram binding and anxiety in Alzheimer disease
S. W. Tsang, C. P. Chen,* P. T. Francis, P. T. Wong, I. Spence,
M. M. Esiri,§ T. Hope§ and M. K. Lai*
*Department of Clinical Research, Singapore General Hospital,
Singapore; Department of Pharmacology, National University of
Singapore, Singapore; Dementia Research Laboratory, King’s
College London, UK; §Department of Neuropathology &
Psychiatry, Oxford University, UK
Late onset Alzheimer disease (AD) is the most common cause of dementia in the
elderly. However, AD is also characterized by neuropsychiatric behaviors like
anxiety. The ﬁnding that the serotonergic system is affected in AD, and that
selective serotonin (5-HT) reuptake inhibitors (SSRIs) are effective in the
treatment of anxiety disorders, led us to query whether alterations in 5-HT
transporter (5-HTT) function may underlie anxiety in AD. In addition, we
examined whether the long variant (L) of a functional polymorphism in the 5-HTT
gene promoter region (5-HTTLPR), which results in increased 5-HTT expression
and 5-HT reuptake, may be associated with anxiety in AD. Therefore, we
measured the afﬁnity and density of 5-HTT sites in the postmortem neocortex by
radioligand binding with [3H]citalopram and correlated the binding parameters
with 5-HTTLPR genotype and prospectively assessed behavioral data. We found
that patients with prominent anxiety had higher densities of [3H]citalopram sites in
the temporal cortex, as well as higher frequencies of the LL genotype, compared
with never-anxious patients. The odds ratio for the LL vs. the SS or SL genotypes
was 6.25 [95% CI (1.14–37.04)]. These results suggest that 5-HTTLPR may be a
risk factor for anxiety in AD via its effect on neocortical 5-HTT expression, and
provides support for the rationale of using SSRIs for the treatment of behavioral
symptoms in AD.
Keywords: Alzheimer’s disease, behavior, gene polymorphism, radioligand,
serotonin uptake.
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Anti-inflammatory effect of lovastatin in multiple
sclerosis by inducing Th2 immune responses involving
GATA3/STAT6 transcription
N. Narender,* G. Shailendra,* S. Avtar and S. Inderjit*
*Department of Pediatrics, Medical University of South Carolina,
Charleston; Department of Pathology Ralph H. Johnson V.A.
Medical Center, Charleston, Charleston, SC, USA
Statins, HMG-CoA reductase inhibitors, used as lipid lowering drugs have
recently been identiﬁed as an immunomodulators. We found that in vivo
treatment of SJL/J mice with lovastatin signiﬁcantly reduces the duration and
clinical severity of active and passive EAE, an animal model of MS.
Lovastatin induced expression of GATA3, which is a master controller of IL-
4, an important Th2 ?cytokine. Lovastatin speciﬁcally inhibited T-bet, a
master regulator of IFN- ?B?B signaling pathway by preventing I?in Th1
cells and inhibited the NF-degradation. Further, it inhibited the tyrosine
phosphorylation of Jak2, Tyk2, and phosphorylation of STAT4 and up-
regulated STAT6 phosphorylation. The inhibition of Jak-STAT4 pathway by
lovastatin resulted in decreased T cell proliferation and Th1 differentiation.
As result of this, Th1 pro-inﬂammatory) were inhibited, thereby inducing the
Th2 (IL4, IL5,? and TNF?cytokines (IFN and IL10) cytokine responses. The
inﬁltration of CD4 and MHC-II positive cells to the CNS was signiﬁcantly
less in treated mice. These ﬁndings strongly B and STAT4?emphasize that
lovastatin attenuated EAE by blocking T-bet, NF-signaling in T cells, while it
induced the Th2 cell related transcription factors (GATA3 and STAT6),
suggesting its use in the treatment of MS and other Th1 cell-mediated
inﬂammatory diseases.
Keywords: cytokines, EAE, signal transduction, statin, T-cells.
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Statins induce MAP kinase-dependent activation of brain
microglia
X. Bi, M. Baudry, J. Liu, L. Fu, Y. Yao and G. Lynch
University of California Irvine, Irvine, USA
Statins are currently being evaluated as potential treatment to reduce the risk
of Alzheimer’s disease (AD). As AD is associated with brain inﬂammation,
we determined the effects of prolonged statin treatment on markers of brain
inﬂammation in cultured hippocampal slices. Treatment with mevastatin or
simvastatin produced a concentration- and time-dependent activation of
microglia throughout the hippocampus. Microglia exhibited both an increase
in number as well as a typical morphological change from slim cell body
with few ramiﬁed processes to round, macrophage-like cells without
processes. Furthermore, a subpopulation of activated microglia exhibited
increased TNFa expression, in particular in the polymorph layer of the
dentate gyrus. Statin-induced microglial changes were prevented by
treatment with mevalonate but not with cholesterol, indicating that the
effects of statins were due to activation of intracellular cascades not related to
cholesterol levels. In addition, these effects were almost completely
prevented by treatment with a MEK inhibitor, PD98059. Our results indicate
that statin treatment of cultured hippocampal slices induces rapid changes in
microglia by interfering with intracellular cascades independent of choles-
terol.
Keywords: cholesterol, cytokines, hippocampus, MAP kinase, microglia,
statin.
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Role of PPARc on amyloid-b generation
M. Sastre, I. Dewachter, E. Rosen, G. Landreth, C. Haass,
T. Klockgether, F. van Leuven and M. T. Heneka
Department of Neurology, University of Bonn, Bonn, Germany
Nonsteroidal anti-inﬂammatory drugs (NSAIDs) have been shown to
decrease the risk and delay the onset of AD. The nuclear hormone receptor
peroxisome proliferator-activated receptor-c (PPARc) is directly activated by
NSAIDs. To determine whether the effects of NSAIDs on APP processing
are mediated by PPARc activation, we incubated N2a cells transfected
APPSW with several pro-inﬂammatory cytokines together with ibuprofen or
PPARc agonists. Total Abwas detected by immunoprecipitation and blotting
or by ELISA. Immunostimulation by inﬂammatory cytokines increased
amyloid-b (Ab) generation. When immunostimulated neuroblastoma cells
were incubated with NSAIDs, PPARc agonists or co-transfected with PPARc
cDNA, the amount of Ab decreased to control levels. These changes were
blocked with PPARc antagonists. To further support our hypothesis, mouse
embryonic ﬁbroblasts PPARc null were used. b-secretase (BACE) activity,
expression and transcription was found altered by these treatments. In
conclusion, our data indicate an effect of inﬂammation on APP cleavage,
apparently dependent on b-secretase activity and suggest that PPARc
mediate protective effects of NSAIDs in AD.
Keywords: Alzheimer’s disease, amyloid, cytokines, inﬂammation, neurob-
lastoma.
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Study of dopaminergic neuron and protein in normal and
parkinsonism conditions in common tree shrew brain
(tupaia glis)
V. Anupunpisit, T. Tantikraisorn and S. Pakdeeronachit
Anatomy department, Faculty of Medicine, Srinakharinwirot
University, Bangkok, Thailand
Parkinson’s disease is a chronic neurodegenerative disorder which is
characterized by the loss of dopaminergic neurons of substantia nigra (SN)
and decreased striatal dopamine levels. We have investigated the dopamin-
ergic neuron in common tree shrew, which is phylogenetically related to
insectivores and primate. Coronal sections through SN and dorsal striatum
(caudate and putamen nuclei) were determined for immunoperoxidase
localization of the dopamine synthesizing enzyme, tyrosine hydroxylase
(TH). The highest densities of TH-labeled neurons were observed in SN area.
Interestingly, the pattern of these neurons is organized as clear and separated
layers, which is very similar to primate brain. Residual dopamine terminals in
striatum showed the lower intensity of TH-labeling. However, the striatum
demonstrated patchy characteristic, which is shared by other mammal brains.
Moreover, immunoblotting analysis revealed strong TH-immunoreativity in
SN but less activity in striatum. The condition of parkinsonism has been
introduced, then the alpha synuclein protein produced in SN would be
implied as the marker of the neuron loss. The immunoreactivity to anti alpha
synuclein has been focused and is now ongoing.Thus, immunological
analysis of TH and alpha synuclein might provide the means for
characterizing and localizing marker proteins in parkinsonism and other
neurological disorders involving dopaminergic system.
Keywords: immunoblotting, immunocytochemistry, neurodegeneration,
Parkinson’s disease, tyrosine hydroxylase.
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Inhibition of the expression of tyrosine hydroxylase in
alpha-synuclein-transfected dopaminergic cells
X. Zuo, S. Yu,* M. Zhou,* Y. Li,* Q. Fu,* Y. Huang,* K. Ueda
and P. Chan*
*Department of Neurobiology; Beijing Institute of Geriatrics,
Xuan Wu Hospital, CUMS, China
The aberrant expression and aggregation of alpha-synuclein (aSyn) has been
demonstrated to be toxic to dopaminergic neurons and has been implicated in
the pathogenesis of Parkinson’s disease. However, little is known about the
correlation of the abnormality of aSyn with the expression of tyrosine
hydroxylase (TH), a rate-limiting enzyme for the synthesis of dopamine
neurotransmitter. In this study, a dopaminergic cell line, MES23.5 was
transfected with pcDNA with wild-type aSyn cDNA construct and stable
transformants were obtained. Immunocytochemical studies revealed that the
number of TH-positive cells were greatly decreased after several passages of
aSyn-transfected cells, while that of vector control cells was not affected.
Western blot analyses demonstrated that the aSyn-transfected cells expressed
much higher aSyn protein when compared with control cells, while the TH
levels in aSyn-transfected cells were dramatically reduced. Confocal laser
microscopy showed that no apparent abnormal aggregates of aSyn were
observed in the aSyn-transfected cells. Although the TH expression in
MES23.5 cells was dramatically inhibited by the presence of a large amount
of aSyn, the growth and proliferation of these cells were not affected.
Apparently, neither necrotic nor apoptotic cell death was observed. These
results suggest that an abnormal expression of aSyn may inhibit TH synthesis
in dopaminergic cells, which may eventually lead to the degeneration of
nigral neurons in diseased brains.
Keywords: alpha-synuclein, Parkinson disease, tyrosine hydroxylase.
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The effect of amyloid precursor protein 17mer peptide on
neurodegeneration in D-galactose induced aging of
murine brain
Z. Yongmei, Z. Zhiwei, J. Zhijuan and S. Shuli
Beijing Research Laboratory for Brain Aging, Xuanwu Hospital,
Capital University of Medical Sciences, Beijing, China
Objective: To observe the effect of beta-amyloid precursor protein (APP)
17mer peptide on memory and learning ability, hippocampal ultrastructure as
well as the expression of neurotrophin-3 (NT-3), nerve growth factor (NGF)
in the brain of D-galactose induced aging of murine brain (DGAM).
APP17mer peptide is the 319–335 peptide sequence of APP.
Methods: DGAM was produced with D-galactose, and APP 17mer peptide
was injected as a therapertic agents. Water maze test, hippocampal
ultrastructural study and immunohistochemistry were done 8 weeks.
Results: (1) APP17mer peptide improved the performance of DGAM in
water maze test. The whole-length swimming time of DGAM protected with
APP17mer peptide was signiﬁcantly shorter with fewer mistakes than that of
DGAM group. (2) Hippocampal neurons of DGAM group showed swelling,
ridge fragmentation, dissolution and disappearance of mitochondria, degran-
ulation of rough endoplasmic reticulum. While the hippocampal neurons of
DGAM treated with APP17mer peptide did not show marked swelling,
mitochondria, rough endoplasmic reticulum had milder damage than that in
DGAM group. (3) DGAM group vs. C group showed signiﬁcantly reduced
expression of NT-3 and NGF in hippocampal neurons on immunohisto-
chemistry. Treatment with APP 17mer peptide normalizes the expression of
NT-3 and NGF in DGAM.
Conclusion: APP17mer peptide may upgrade the biochemical function of
neurons through enhancing the synthesis of NT-3 and NGF in the brain of
DGAM. APP17mer peptide improves the neurodegeneration caused by
D-galactose.
Keywords: aging, amyloid precursor protein, nerve growth factor, neurode-
generation, neurotrophins.
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Methionine oxidation and the toxic principle of the
b-amyloid peptide from Alzheimer’s disease
K. J. Barnham, G. D. Ciccotosto, A. K. Tickler, F. E. Ali,
D. G. Smith, N. A. Williamson, Y. H. Lam, D. Carrington, D. Tew,
G. Kocak, I. Volitakis, F. Separovic, C. J. Barrow, J. D. Wade,
C. L. Masters, R. A. Cherny, C. C. Curtain, A. I. Bush and
R. Cappai
Department of Pathology, The University of Melbourne, and The
Mental Health Research Institute of Victoria, Australia
The amyloid b-peptide is toxic to neurons and it is believed that this toxicity
plays a central role in the progression of Alzheimer’s disease. The
mechanism of this toxicity is contentious. Here we report that an Ab peptide
with the sulfur atom of Met35 oxidized to a sulfoxide is toxic to neuronal
cells and this toxicity is rescued by catalase and the metal chelator clioquinol.
Rescuing the toxicity with catalase implicates H2O2 in toxicity. Unlike the
unoxidized peptide, Met(O)Ab is unable to penetrate lipid membranes to
form ion channel-like structures and b-sheet formation is inhibited,
phenomena that are central to some theories for Ab toxicity. Our results
show that, like the unoxidized peptide, Met(O)Ab will coordinate Cu2+ and
reduce the oxidation state of the metal, and so still produce H2O2.
Keywords: Abeta, Alzheimer’s disease, amyloid, oxidation, toxicity.
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Two monoclonal antibodies reveal distinct subcellular
localizations of a-synuclein immunoreactivity in the rat
brain
S. Yu, Y. H. Li, M. Zhou, X. M. Liu, X. H. Zuo and P. Chan
Department of Neurobiology, Xuan Wu Hospital, Capital University
of Medical Sciences, Beijing, China
a-Synuclein has been implicated in the pathogenesis of Parkinson’s disease.
However, the function of this protein remains unclear. Although the protein
was initially nominated as synuclein for its localizations in both presynaptic
terminals and nucleus of the neuron, the nuclear location has not been
consistently conﬁrmed by the subsequent studies. In the present study, by
using recombinant human a-synuclein to immune Balb/c mice, fusing the
spleen cells with the myeloma cells, and screening the hybridoma cells with
ELISA, immunohistochemistry and Western blot, we successfully obtained
two clones that produced monoclonal antibodies speciﬁcally against a-
synuclein. Both of the antibodies detected a 18 kD protein in either the rat
brain homogenate or the human brain homogenate, which was completely
absorbed by pre-incubation of the antibodies with the human recombinant a-
synuclein. Both antibodies stained the a-synuclein in the Lewy body and
Lewy neurite in the brain of patient with Parkinson’s disease. Very
interestingly, when the two antibodies were applied to the rat brain
immunohistochemically, they revealed distinct localizations of the a-
synuclein immunoreactivity, with one antibody detecting the a-synuclein in
only the synaptic terminals and another one in both the presynaptic terminals
and the nuclei of the neuron. As the two antibodies recognized the different
parts of the a-synuclein according to the epitopes demonstrated by phase
polypeptide display technique, we suggest that the distinct subcellular
localization of a-synuclein in the neuron may imply a conformational change
or modiﬁcation of the protein between the nucleus and the presynaptic
terminal.
Keywords: a-synuclein, brain, immunohistochemistry, monoclonal antibody,
neuron.
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Intermolecular interaction between a-synuclein and
tyrosine hydroxylase in the regulation of dopamine
biosynthesis
Y. H. Li, H. Yu, S. Yu, X. M. Liu, A. Zhang and P. Chan
Department of Neurobiology, Xuan Wu Hospital, Capital University
of Medical Sciences, Beijing, China
Objective: To investigate the effects of a-synuclein on dopamine
biosynthesis.
Methods: Both recombinant proteins a-synuclein and tyrosine
hydroxylase were prepared by E. coli expression. The activity of the
tyrosine hydroxylase was assayed by measuring the concentration
of L-Dopa derived from L-tyrosine. And intermolecular interaction
between a-synuclein and tyrosine hydroxylase were analysed by
polyacrylamide gel electrophoresis and western blot.
Results: The activity of tyrosine hydroxylase was markedly
decreased with presence of a-synuclein. On the contrary, tyrosine
hydroxylase appears to interact with a-synuclein and affects its
kinetics.
Conclusion: Our data suggest that the activity of tyrosine
hydroxylase can be affected by a-synuclein.
Keywords: a-synuclein, biosynthesis, dopamine, intermolecular
interaction, tyrosine hydroxylase.
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The effects of mutations in tau on microtubule assembly
I. Ginzburg, A. Lange, H. Levi and H. Rosenmann
Neurobiology Department, Weizmann Institute of Science, Rehovot,
Israel
Tau proteins, are located mainly in neuronal cell body and axons,
and function in microtubule (MT) assembly and stabilization. In
neurodegenerative disorders including Alzheimer’s disease tau
proteins aggregate into paired helical consisting of hyperphosphor-
ylated tau,which binds poorly to microtubules. PP2A phosphatase
colocalized on microtubules and dephosphorylates tau. We have
characterized the double mutant P301S and K257T, associated with
severe AD phenotype and add potential sites for phosphorylation.
Biochemical and morphological analyses performed in the P19
stable living cell line demonstrate that the double mutant tau
protein: (a) does not co-localize with MTs in vivo; (b) cannot
associate efﬁciently with MTs and promote their assembly; (c) does
not contribute to neurite formation; (d) upon neuronal differenti-
ation, aggregates of tau proteins are observed, which are not
colocalizeded with MTs; (e) tau biochemical properties; heat
stability and acid solubility are not affected. The ability of wild
type and dominant negative forms of PP2A to co-assemble into
MTs, adjacent to tau is tested. This research will investigate the
interactions between tau and PP2A, and their effect on tau
dephosphorylation, MT structure, and assembly in neuronal cells.
In addition, these mutations do not show gross changes in the
biochemical characteristic of tau, may focus testing pharmacologi-
cal treatments to prevent or dissolve the pretangle aggregates
formed.
Keywords: Alzheimer’s disease, axon, microtubule proteins,
neurons, tau protein.
P09-35
The oxidative stress effect of 1-methyl-4-phenyl-
pyridinium on dopaminergic cell line MES23.5
H. Ding, X. S. Li, Z. X. Hong, X. Y. Ling and C. Biao
Beijing Geriatric Institute, China
The pathological character of Parkinson’s Disease (PD) is the loss of
dopaminergic neuron in substantia nigra. The etiology of dopam-
inergic neuronal death in PD remains elusive. The environmental
factors are becoming more and more emphasized in recent years.
1-methyl-4-phenyl-pyridinium (MPP+), the reactive metabolite of
1-methyl-4-phenyl-1,2,3,6-tetrahydropypridine (MPTP), one of the
environment factors, is the inhibitor of mitochondrial complex I. In
our research, we found that MPP+ can reduce the viability of
dopaminergic cell line MES23.5. Cellular viability was signiﬁcantly
decreased under the higher concentration (more than 200 mM) in a
concentration and time dependent manner. After exposure to MPP+,
the OH-, superoxide dismutase (SOD), mitochondrial membrane
potential (AWM), reactive oxidant species (ROS) were changed
respectively. Our results suggest that the oxidative stress plays an
important role in the toxic effect of MPP+ on dopaminergic cell
MES23.5.
Keywords: cell death, dopamine, mitochondria, oxidative stress,
Parkinson’s disease.
P09-36
Caspase-3 activity is induced by cerebrospinal fluid from
multiple sclerosis patients in neuronal cells
C. Cid, J. C. A´lvarez-Cermen˜o, J. Plaza, M. Salinas and A. Alca´zar
Serv. Bioquı´mica-Investigacio´n and Neurologı´a, Hospital Ramo´n y
Cajal, Madrid, Spain
Neuronal apoptosis has recently been implicated in multiple
sclerosis (MS), a demyelinating disease of the central nervous
system. Cerebrospinal ﬂuid (CSF) from MS patients induces
apoptotic cell death of neurons in culture, and apoptotic neurons
have been identiﬁed in MS lesions and in experimental autoimmune
encephalomyelitis (EAE). Caspases are essential for the regulation
of apoptosis. Among them, caspase-1 and caspase-3 play a crucial
role in the inﬂammatory process and in the execution step of
apoptosis respectively. The activity of these caspases in neurons
treated with CSF from MS patients is studied. Besides, we
determine whether it is possible to rescue neuronal cells using
apoptotic inhibitors. Caspase-like enzyme activity was measured in
cell extracts from CSF-treated cultured neurons by a ﬂuorimetric
assay based on the cleavage of Ac-YVAD-amc and Ac-DEVD-amc
for caspase-1 and caspase-3 activities respectively. Treatment of
neuronal cells with MS CSF signiﬁcantly induced caspase-3
activity, whereas caspase-1 activity was not induced. This
caspase-3 activity was inhibited in vitro by z-VAD-fmk and Ac-
DEVD-cmk. These two caspase inhibitors were used to treat in vivo
CSF-incubated neuronal cells. Examination of neuronal survival by
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) assay and DNA fragmentation detected in situ by terminal
deoxynucleotidyl transferase-mediated dUTP nick-end labeling
(TUNEL) revealed that these caspase inhibitors completely blocked
the MS CSF-induced neuronal death. These ﬁndings show that
neuronal cells were rescued from MS CSF-induced death by
caspase inhibitors and support an important role for caspase-3 in
apoptotic signaling pathway in MS disease.
Keywords: apoptosis, caspases, cerebrospinal ﬂuid, multiple
sclerosis, neurons.
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Correlation of very long chain fatty acids accumulation
and inflammatory disease progression in childhood
X-ALD
A. S. Paintlia,* A. G. Gilg,* M. Khan,* A. K. Singh, E. Barbosa*
and I. Singh*
*Department of Pediatrics, Medical University of South Carolina;
Department of Pathology and Laboratory Medicine, Medical
University of South Carolina and Ralph H. Johnson V. A. Medical
Center, Charleston, SC, USA
Childhood adrenoleukodystrophy (cALD) is the most frequent clinical phenotype
of the defective X-ALD gene, resulting in accumulation of very long chain fatty
acids (VLC fatty acids) with subsequent inﬂammatory demyelination and death in
children. The study was carried out to understand the role of inﬂammatory
mediators involved in the neurobiology of cALD by comparing the differential
expression of the inﬂammatory mediators. Histopathological examinations of brain
sections indicated extensive demyelination and accumulation of inﬁltrates in
perivascular cuffs in plaque area (PA) and inﬂammatory area (IA) compared with
normal looking area (NLA) of the cALD and controls. The PA had the excessive
accumulation of cholesterol ester (25–30-fold), VLC fatty acids (eight to 12-fold)
and exhaustive depletion of cholesterol (60–70%) and sphingomyelin (50–55%) in
comparison with controls. The mRNA expression of cytokines (IL-1a, IL-2, IL-3,
IL-6, TNF-a and GM-CSF), chemokines (CCL2, -4, -7, -11, -16, -21, -22, CXCL1,
CX3CL1 and SDF-2) and iNOS in IA was signiﬁcantly increased compared with
NLA of the cALD and controls determined by super gene array, semi-quantitative
RT-PCR and immunohistochemistry. These results indicate that accumulation of
VLC fatty acids contents in the membrane domains associated with signal
transduction pathways may trigger the inﬂammatory process through activation of
resident microglia and these resulting in loss of myelin and oligodendrocytes.
Keywords: human childhood X-ALD brain, inﬂammatory cytokines and
chemokines, super gene array, very long chain fatty acids.
P09-38
Experimental destruction of substantia nigra
dopaminergic neurons initiated by lipopolysaccharide
J. Liu, S. Chen and Z. Liu
Department of Neurology, Rui Jin Hospital, Shanghai, Peoples
Republic of China
Objective: To study lipopolysaccharide (LPS)-induced injury of substantia nigra
dopaminergic neurons and investigate the relationship between immunity and the
pathogenesis of Parkinson’s disease (PD).
Methods: Lipopolysaccharide was stereostatically injected into left substantia
nigra of rats. 14, 21 and 28 days after injection, the circling behavior was observed
by intraperitoneal injection of apomorphine, midbrain dopaminergic neurons were
identiﬁed by using tyrosine hydroxylase (TH) immunohistochemistry, the contents
of dopamine and its metabolite in the striatum and substantia nigra were measured
by high performance liquid chromatography (HPLC), and the nigral neuronal
apoptosis was detected by TUNEL, double-labelling for microglia and inducing-
nitricoxide synthase (iNOS) was performed to visualize brain slides.
Results: The circling behavior ipsilateral to LPS injected-side was induced in
some rats 21 and 28 days following injection, but not 14 days. Compared with the
PBS-treated rats, the marked loss of TH-positive cells in left substantia nigra was
identiﬁed 21 and 28 days after LPS treatment, but 14 days. The 30–70% reduction
of dopamine and its metabolite (DOPAC) of the left striatum and substantia nigra
was found at 21 and 28 days following injection, whereas no signiﬁcant change
was observed at 14 days. At the same time, 21 and 28 days after LPS injection,
positive double-labelling immunostaining for microglia and iNOS was seen in the
injuried substantia nigra, but not 14 days after LPS injection.
Conclusions: LPS intranigral injection could injury the dopaminergic neurons in
the substantia nigra. Thus, it suggests that immunity may be involved in the
pathogenesis of Parkinson’s disease.
Keywords: dopamine, lipopolysaccharide, microglia, Parkinson’s disease.
P09-39
Developmentally induced oxidative stress coincides with
beta-amyloid plaque deposition in transgenic Tg2576
mice
J. Apelt and R. Schliebs
Paul-Flechsig-Institute for Brain Research, University of Leipzig,
Leipzig, Germany
The molecular mechanisms of beta-amyloidogenesis in Alzheimer’s disease are
still poorly understood. Anti-inﬂammatory and antioxidant agents have been
observed to delay onset or to slow down the progression of Alzheimer’s disease.
To reveal whether oxidative stress and local inﬂammatory events may trigger or
contribute to beta-amyloid deposition, a transgenic mouse (Tg2576) that express
the Swedish double mutation of human amyloid precursor protein and develop
Alzheimer-like beta-amyloid deposits at late ages may represent an appropriate
approach. In Tg2576 mouse brain, cortical levels of beta-amyloid (1–40) and (1–
42) steadily increase with age, but signiﬁcant deposition of ﬁbrillary beta-amyloid
into cortical areas does not occur before postnatal age of 10 months. The aim of
the present study was to address the hypothesis whether the age-related occurance
of oxidative stress and proinﬂammatory cytokines coincide with the developmental
pattern of beta-amyloid plaque deposition in Tg2576 mouse brain. The activities of
superoxide dismutase assayed in cerebral cortical tissue from Tg2576 mice steadily
increased between postnatal ages of 9 and 12 months at which age the highest
activity during the whole period of life was detected. A similar developmental
proﬁle was observed for the activity of glutathion peroxidase. The levels of cortical
nitric oxide, reactive nitrogen species (NOx), and interleukin-1beta demonstrated
peak values around 9 months of age. The developmental temporal coincidence of
increased levels of reactive nitrogen species and antioxidative enzymes with the
onset of beta-amyloid plaque deposition strongly suggests the involvement of
oxidative stress in triggering beta-amyloidogenesis.
Keywords: Alzheimer’s disease, amyloid, nitric oxide, superoxide dismutases,
transgenic mouse.
P09-40
Oxidative stress induced intranuclear accumulation of
a-synuclein in MES23.5 dopaminergic neurons
S. Xu, M. Zhou, A. Zhang and P. Chan
Beijing Geriatrics Institution, Beijing, China
Parkinson’s disease is the most common movement disorder of the elderly. Its
pathological characteristics are the loss of dopaminergic neurons in the substantia
nigra. So far, the mechanisms underlying neurodegeneration in PD are unknown,
but the ﬁndings that a-synuclein accumulates in Lewy bodies and the mutations of
a-synuclein cause familial PD suggest that a-synuclein participates in the
pathophysiology of PD. Some studies have shown that oxidative stress is involved
in the neuronal degeneration and can promote the aggregation of a-synuclein in the
cytoplasm. We set to further investigate the role of a-synuclein in oxidative stress
induced toxicity in dopaminergic neurons. In our study, MES23.5 cell line were
treated with H2O2 (200 lM) and harvested at 10 min, 30 min, 1 h, 2 h, 4 h and 8 h
following the treatment respectively. Fluorescent double labeling was performed
using anti-tyrosine hydroxylase (TH) and anti-a-synuclein primary antibodies;
Thioﬂavine S staining was coupled with a-synuclien immunoﬂuorescent staining.
The cytoplasmic and nuclear protein were extracted respectively for western blot.
Results: a-Synuclein-like immunoactivity in the cytoplasm was decreased in a
time-dependent manner after the cells exposure to H2O2. However, accumulation
of a-synuclein appeared in the nuclei at H2O2 treatment 10 min, and rapidly
increased up to 8 h, while the TH expression also reduced in a time-dependent
manner. The thioﬂavine S staining showed that the a-synuclein in nuclei is not
aggregated.Our data indicate that the H2O2 treatment can induce the intranuclear
accumulation of a-synuclein in dopaminergic neurons, but further study is needed
to reveal the exact role of a-synuclein in response to oxidative stress in
dopaminergic neuron.
Keywords: neurodegeneration, neurons, neurotoxins, oxidative stress, tyrosine
hydroxylase.
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Locus ceruleus cell death and noradrenaline depletion
augments learning and memory deficit in APP2576
transgenic mice
M. Ramanathan, L. Dumitrescu-Ozimek, M. Sastre, T. Klockgether
and M. T. Heneka
Department of Neurology, University of Bonn, Bonn, Germany
Locus ceruleus (LC) degeneration and subsequent loss of noradrenergic
terminals in projection areas are an early event in the course of Alzheimers
disease (AD). Memory deﬁcits in mice overexpressing human amyloid
precursor protein APP2576 have been correlated with increased Ab deposits,
and synaptic and cholinergic dysfunction. The consequences of LC
degeneration for AD have not yet been clariﬁed. We used APP2576 mice
to test whether noradrenergic depletion increases changes of behaviour,
memory and neuronal integrity. APP2576 and control mice received a
systemic injection of selective neurotoxin DSP4 and after six months of
injection, mice were subjected to open ﬁeld exploration, spatial memory test
and brain immunohistochemical evaluation for different markers. The results
suggest that APP2576 mice exhibited working and reference memory deﬁcits
in radial arm maze compared with wild-type controls. DSP4 aggravated the
observed cognitive deﬁcit and produced anxiety in comparison with
untreated APP2576 mice. Furthermore neuronal evaluation with neuN, acid
fuchsin and Fluro-Jade staining and Ab immunostaining indicate increased
neuronal loss along with Ab deposits in frontal cortex and hippocampus of
APP2576 mice. The ChAT positive neurones in oriens, lacunosum and
radiatum areas were found to be signiﬁcantly reduced with DSP4 treatment.
In conclusion, depletion of the noradrenergic system augments Ab
accumulation, neuronal cell death, behavioural alterations and memory
deﬁcits in APP2576 transgenics but not in wild-type controls. This result
suggests that early LC degeneration is permissive for Ab-induced neurode-
generative alterations and may therefore contribute to the course of AD.
Keywords: amyloid beta, behaviour, cholineacetyl tranferase, noradrenaline,
transgenic mouse.
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Nitric oxide donors protect against 1-methyl-4-phenyl
pyridinium-induced experimental parkinsonism in rats:
evidence for antioxida
R. Banerjee, K. S. Saravanan, K. M. Sindhu and
K. P. Mohanakumar
Division of Neurosciences, Indian Institute of Chemical Biology,
Calcutta, India
Nitric oxide (NO) with free radical properties plays a controversial critical
role under a variety of physiologic and pathologic conditions. We
investigated the effects of NO donors such as S-nitroso-N-acetylpenicillam-
ine (SNAP), 3-morpholinosydnonimine hydrochloride (SIN-1), sodium
nitroprusside (SNP) and nitroglycerin (NG) in nigrostriatal dopaminergic
toxicity caused by the potent parkinsonian neurotoxin, 1-methyl-4-phenyl-
pyridinium (MPP+) in vivo in rats and in MPP+ induced hydroxyl radical
(.OH) generation in mitochondria in vitro. NG, SNAP and SIN-1 caused
signiﬁcant attenuation of MPP+ induced .OH generation in mitochondria.
Administration of MPP+ by intranigral infusion in rats to produce
nigrostriatal damage was signiﬁcantly attenuated by co-infusion of NG,
SNAP and SIN-1 but not by SNP. NG, SNAP and SIN-1 exposed for 48 h to
remove NO when administered similarly, failed to protect against MPP+
induced neurotoxicity in vivo. Long-term exposed SNP when administered
intranigrally, caused dose-dependent depletion of striatal dopamine. These
results indicate that selective NO donors can protect dopaminergic
neurotoxicity caused by MPP+ by releasing NO in the nigral region and
by virtue of its OH scavenging action. This study warrants the neuropro-
tective role of NO in dopaminergic neurodegeneration.
Keywords: neurotoxins, nitric oxide, Parkinson’s disease, striatum, substantia
nigra.
P09-43
Ab sequestration in the periphery as a possible
therapeutic approach for Alzheimer’s disease
Y. Matsuoka and K. Duff
Center for Dementia Research, Nathan Kline Institute/New York
University School of Medicine, Orangeburg, New York, USA
Amyloid beta (Ab) is one of the pathological features of Alzheimer’s disease
and the reduction of Ab is considered a primary therapeutic target. Reduction
of Ab is considered a primary therapeutic target of Alzheimer’s disease
(AD). One of the proposed therapeutic approaches for AD has been the
reduction of brain Ab by raised (or passively injected) anti-Ab antibodies.
Through vaccination in mice, plasma Ab was signiﬁcantly enhanced
concomitant with a reduction of brain Ab, suggesting that the anti-Ab
antibodies may act as a peripheral sink as well as an activator of microglial
phagocytosis. Here, we have investigated whether agents with high Ab
binding afﬁnity might be effective in altering the periphery/brain dynamics
leading to a reduction of brain Ab. We treated two amyloid-forming
transgenic mice with agents, gelsolin and GM1, that have high afﬁnity for
Ab, but which are unrelated to an immune modulation, for 2–3 weeks by
intraperitoneal injections. After drug treatment, the level of brain Ab was
signiﬁcantly reduced, and in some treatment protocols, plasma Ab was
signiﬁcantly enhanced. However, direct brain infusion with an Ab binding
agent did not reduce insoluble brain Ab, indicating that Ab binding agents
can reduce brain Ab without entering the brain. Overall, we found that Ab
binding agents could signiﬁcantly reduce AD-type brain amyloidosis without
entering the brain. We propose that in general, compounds that sequester
plasma Ab in the periphery could reduce or prevent brain amyloidosis, thus
suggesting new therapeutic or prophylactic options that may be more
ﬂexible, more reliable and less likely to cause side-effects than immunization
based therapies.
Keywords: Alzheimer’s disease, amyloid, transgenic mouse.
P09-44
Inactivation of glycogen synthase kinase by estrogen
receptor and its implications to Alzheimer’s disease
pathogenesis
S. Goodenough, C. Pietrzik, D. Manthey, E. Koo and C. Behl
Institute of Physiological Chemistry and Pathobiochemistry,
Johannes Gutenberg University, Mainz, Germany
The sex steroid hormone estrogen exerts a diverse array of biological
functions both during development and in the adult, also including
nonreproductive organs such as the brain. Moreover, estrogen has been
proposed to mediate neuroprotection and to act as a preventive compound in
neurodegenerative disorders such as Alzheimer’s Disease (AD). Here we
examine estrogen’s role in key pathological processes associated with AD.
We found that in neuronal cells estrogen induced an increased phosphory-
lation at ser-9, and therefore inhibition, of glycogen synthase kinase 3b
(GSK), a modulator of nerve cell survival and a kinase involved in the
hyperphosphorylation of tau. This inhibition is estrogen receptor (ER)
dependent and is mediated via the activation of the MAPKinase pathway.
Further, ERa coimmunoprecipitates with GSK, representing one potential
mechanism for GSK inhibition. The inactivation of GSK also occurred in
vivo, particularly in the hippocampus, a prime target in neurodegeneration.
The implications of these ﬁndings were then examined with respect to
AD-associated pathological processes. First, GSK may regulate the estrogen-
driven increase in sAPPa release from neuronal cells. The inhibition of GSK
with lithium chloride increased sAPPa and decreased total Ab release in APP
overexpressing cells. Secondly, estrogen decreased the GSK-mediated
hyperphosphorylation of tau in vivo. Taken together, we have found a novel
functional and molecular link between estrogen and GSK. In addition, we
have established a molecular link between estrogen and GSK to central
process of the pathogenesis of AD.
Keywords: Alzhiemer’s disease, amyloid, estradiol, tau protein.
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Cholesterol oxidase activity mediates neurotoxicity of the
Alzheimer b-amyloid cuproprotein
A. I. Bush, L. Puglielli, S. Nagano and D. M. Kovacs
Massachusetts General Hospital, Charlestown, MA, USA
Beta-amyloid (Ab) accumulation is causally related to the pathogenesis of
Alzheimer’s disease, however the mechanism of neuronal demise is unclear.
Both cholesterol metabolism and brain metal dyshomeostasis are implicated
in AD pathogenesis. We have previously characterized Ab as a metallopro-
tein that possesses redox active, high-afﬁnity Cu2+ binding sites. Oligomeric
complexes of Cu2+/Ab catalyze the generation of hydrogen peroxide using
O2 and biological reducing agents as substrates. Cu
2+/Ab insert themselves in
to lipid membranes, and so we characterized the ability of these complexes
to utilize cholesterol as a substrate for hydrogen peroxide formation. We
found that Cu2+/Ab converts cholesterol into a well-known pro-apoptotic
neurotoxin, cholestene-3b-one, in a catalytic manner (Km ¼ 5.2 lM,
Vmax ¼ 46 nM/min) that is inhibited by chelators, such as clioquinol. This
activity is accompanied by hydrogen peroxide production and is greatest for
Ab 42 > Ab 40  rat Ab, paralleling the involvement of these peptides in
neuropathology. In cell culture, the toxicity of Cu2+/Ab correlates with the
conversion of cellular cholesterol to cholestene-3b-one. Inhibition of this
rogue activity may contribute to the potential therapeutic effectiveness of
both clioquinol (a chelator) and statins.
Keywords: Alzheimer’s disease, amyloid, cholesterol, copper, oxidative
stress.
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Dopamine dynamic changes and behavioural
assessment in advanced Parkinson’s disease and
levodopa induced dyskinesia models
W. M. Zhu, D. I. Finkelstein, K. D. Buxton, J. Drago and
M. K. Horne
Department of Neurology, Monash University, Clayton, Australia
In previous studies we showed that following partial lesions of the Substantia
nigra (SNpc), surviving dopaminergic (DA) neurones sprout and reinnervate
the striatum. We have also shown that the terminals newly formed by
sprouting have impaired function of the dopamine transporter (DAT). In
Parkinson’s Disease (PD) there is progressive loss of SNpc DA neurones and
chronic levodopa treatment almost always results in dyskinesia. We have
hypothesized that in PD compensatory sprouting and the associated terminal
dysfunction may be responsible for both dyskinesia and also motor
ﬂuctuations. This study examined this hypothesis. Rats and marmosets
received partial lesions of the SNpc and were left until compensatory
sprouting would have occurred. Voltammetry was used to measure DA
reuptake from synaptosomes and in vivo and DA release. Animals received
L-dopa, which induced dyskinesia in the marmosets. Both in vivo and in vitro
studies showed that DA uptake was functionally impaired following SNpc
damage, but that the D2 receptor was functional in that application of a D2R
agonist causing increased DA uptake. DA release induced by medial
forebrain bundle (MFB) stimulation was not decreased. The release and
uptake of DA in the reinnervated striatum was measured and this was
compared with normal and following a dose of L-dopa. In marmosets, the
response will be correlated with the degree of dyskinesia. These results
indicate that the decrease in dopamine uptake of regenerated terminals
combined with the increased terminal arbour could be the basis for both
dyskinesia of Parkinson’s Disease and tardive dyskinesia.
Keywords: L-dopa, dopamine, neurotransmitter, Parkinson’s disease, stria-
tum.
P09-47
Specific degeneration of beta-amyloid-associated
cholinergic structures in transgenic APPsw mice
A. O. Ihunwo, H.-J. Luth, J. Apelt, T. Arendt and R. Schliebs
Mbarara University Medical School, Mbarara, Uganda
Cholinergic dysfunction is a consistent feature of Alzheimer’s disease and the
interrelationship between beta-amyloid deposits, inﬂammation and early
cholinergic cell loss is still not fully understood. To characterize the
mechanisms by which beta-amyloid and proinﬂammatory cytokines may
exert speciﬁc degenerating actions on cholinergic cells ultrastructural
investigations by electron microscopy were performed in brain sections
from transgenic Tg2576 mice that express the Swedish double mutation of
the human amyloid precursor protein and progressively develop beta-amyloid
plaques during aging. Both light and electron microscopical investigations of
the cerebral cortex of 19-month-old transgenic mice revealed a number of
pathological tissue responses in close proximity of beta-amyloid plaques,
such as activated microglia, astroglia proliferation, increased number of
ﬁbrous astrocytes, brain edema, degeneration of nerve cells, dendrites and
axon terminals. Ultrastructural detection of choline acetyltransferase (ChAT)-
immunostaining in cerebral cortical sections of transgenic mice clearly
demonstrated degeneration of ChAT-immunoreactive ﬁbers in the environ-
ment of beta-amyloid plaques and activated glial cells suggesting a role of
beta-amyloid and/or inﬂammation in speciﬁc degeneration of cholinergic
synaptic structures.
Keywords: Alzheimer’s disease, choline acetyltransferase, glia, inﬂamma-
tion, ultrastructure.
P09-48
Staurosporine prevents inhibitory effect of amyloid b1-42
on hemicholinium-3 sensitive choline transport in
NG108-15 cells
V. Dolezal, J. Novakova, V. Lisa and S. Tucek
Institute of Physiology CAS, Prague, Czech Republic
Cholinergic cell line NG108-15 (1) enhances its neuronal and cholinergic
phenotype during differentiation induced by simultaneous presence of cAMP
and dexamethasone in growth medium. Amyloid b1–42 (Ab) present in
growth medium in submicromolar concentrations during differentiation
prevents the expression of functional N-type calcium channel. Now we have
investigated an inﬂuence of Ab on a cholinergic marker, hemicholinium-3
(HC-3) sensitive choline uptake, in control and differentiated cells. Four-day-
lasting differentiation resulted in an increase of both HC-3 binding and HC-3
sensitive choline uptake. Submicromolar concentrations of Ab present in
growth medium during differentiation reduced the increase of HC-3 binding
in a concentration-dependent manner and at a concentration of 100 nM also
choline uptake. In contrast, Ab present only during measurement at a
concentration of 1 lM was not effective. In differentiated cells, staurosporine
(100 nM) increased whereas tetradecanoylphorbol acetate (TPA; 1 lM)
decreased choline uptake when present 5 min prior to and during
measurement. In Ab treated cells staurosporine also increased choline uptake
while TPA lost its inhibitory effect. Both staurosporine and TPA when
included in growth medium during differentiation together with Ab reversed
its inhibitory effect. These observations indicate that protein kinase C
regulates choline uptake and that the inhibitory effect of Ab at submicro-
molar concentrations may be mediated by a persistent increase of protein
kinase C activity.
Keywords: amyloid, choline uptake, cholinergic neuron, differentiation,
protein kinase.
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P09-49
Gene expression profile changes in the caudate of PD
patients
P. Chan, P. B. Chan and Y. Cai
Beijing institute of Geriatric, Beijing, China
Objective: To understand the gene expression proﬁles in the caudate of PD
patients.
Methods: Genes differentially expressed in caudates of PD patients were detected
using affymatrix-chips which provided an analysis of 7070 genes in total. In
comparison with matched normal control, 170 genes have shown an altered
expression pattern, including 47 turned up, and 123 turned down. These genes are
associated with multiple physiological functions, such as oxidative stress,
transcription regulation, signal transduction pathway, and neurotransmission etc.
Conclusion: Multiple physiological processes as well as genes are thought to be
associated with Parkinson disease. The importance of maintaining both the release
of neurotransmitters and regulative interplay among different neurons was also
discussed.
Keywords: chip, dopamine, Parkinson’s disease.
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Characterization of a-synuclein in human lymphocytes
S. H. Kim,* C. J. Heo,* P. S. Im,* T. B. Ahn, B. S. Jeon and
Y.-H. Suh*
*Department of Pharmacology, College of Medicine, National
Creative Research Initiative Center for Alzheimer’s dementia and
Neuroscience Research Institute, MRC, Seoul National University,
Seoul; Department of Neurology, Seoul National University,
College of Medicine, Clinical Research Institute and MRC, Seoul
National University Hospital, Seoul, Republic of Korea
Human a-synuclein is a 140 amino acid protein with little or no secondary
structure. a-Synuclein is expressed at high levels in the brain and enriched in
neural synaptic terminals but its physiological function remains largely unknown.
More recently, a-synuclein has been shown to be one of the principal components
of Lewy bodies, neuronal inclusions that are found in diverse human neurode-
genrerative disorder including the Lewy body variant of Alzeheimer’s disease,
diffuse Lewy body disease, Parkinson’s disease, multiple system atrophy.
Therefore, a-synuclein and its abnormal protein aggregation have been thought
to play a role in the pathogenesis of these neurodegenerative diseases known as
a-synucleinopathies. In order to understand their etiology and pathogenesis, it is
crucial to identify the normal function of a-synuclein. It was previously reported
that the splicing ?variant of a-synuclein is expressed in heart, skeletal muscle, and
pancreas. In our study, we identiﬁed the expression in spleen and conﬁrmed the
expression of a-synuclein in isolated human PBMC. The physiological role in
lymphocytes showed relationship with apoptosis, induction of caspase-8, and
caspase-9 with inﬂammatory cytokines. This result suggest that the accumulated
a-synuclein might be involved in regulation of cell viability by the interaction with
proteins such as synphilin-1.
Keywords: apoptosis, caspase, lymphocyte, neurodegeneration, Parkinson’s
disease.
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Development of mtDNA-transfused cell models of
Alzheimer’s disease and application in Chinese herb
study
L. Zhang, L. Li and F. Liu
Department of Pharmacology, Xuan-wu hospital of CUMS, Beijing,
P.R. China
Objective: To develop mtDNA-transfused cell models (cybrids) of Alzheimer’s
disease (AD), observe the pathological characteristics of cybrids, and investigate
the pharmacological effects of Chinese herb component SSY-p3 on the cybrid
models.
Methods: The q0 cells without mitochondria were fused with the platelets from AD
patients, aged and young donors. Cytochrome oxidase (COX) activity was
determined by microplate assay. The speciﬁc fragment of mtDNAwas detected by
PCR and gel electrophoresis. Reactive oxygen species (ROS), mitochondrial
membrane potential (MMP) and cytosolic calcium were determined by laser
scanning confocal microscopy and ﬂow cytometry.
Results: (1) The successful development of cybrids was veriﬁed by the evidence
that cybrids grew and proliferated well in selective medium without uridine,
recovered COX activity and had the mtDNA-speciﬁc fragment. (2) COX activity in
AD cybrids decreased compared with aged and young control (p < 0.05). (3) ROS
in AD cybrids was higher than that in aged and young control (p < 0.05).
Incubation of Chinese herb component SSY-P3 (100 lg/mL) with AD cybrids for
24 h declined their ROS production. (4) MMP of AD cybrids was lower than that in
aged and young control (p < 0.01). SSY-P3 Incubation elevated their MMP by
80.4% (p < 0.05). (5) In comparison of young control, the basal cytosolic calcium
of AD cybrid was increased, and the regulatory ability to calcium was decreased.
SSY-P3 decreased basal cytosolic calcium and enhanced regulatory ability to
calcium in AD cybrids.
Conclusion: mtDNA transfused cells (cybrids) of AD can be used as a good
model to investigate the pathogenesis related to mitochondria and to screen the
drugs. Chinese herb component SSY-P3 may be beneﬁcial to retarding or treating
Alzheimer’s diseases.
Keywords: Alzheimer’s disease, calcium, free radicals, membrane potential,
mitochondria.
P09-52
The parkinsonian neurotoxin, 1-methyl-4-phenyl
pyridinium (MPP+), affects voltage activated calcium
channels in DRG neurons
G. Chandra,* D. Bu¨sselberg and K. P. Mohanakumar*
*Division of Neurosciences, Indian Institute of Chemical Biology,
Calcutta, India; Physiologie, Universita¨tsklinikum Essen, Essen,
Germany
Administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes
parkinsonian syndromes in human and animals, which is featured by hypoactivity
of dopamine (DA) neurotransmitter system resulting from degeneration of
dopaminergic neurons of substantia nigra pars compacta (SNpc) region of the
brain. NMDA receptor-mediated cell death, altered intracellular Ca2+ homeostasis,
and functional run-down of ligand-gated (GABAA) channels of dopaminergic cells
are some propositions that point to an active involvement of membrane
depolarization as an initial event in MPTP-neurotoxicity. In the present study,
we reported the effects of MPTP and and its active neurotoxic metabolite,
1-methyl-4-phenyl pyridinium ion (MPP+) on voltage-activated inward currents of
cultured dorsal root ganglia (DRG) neurons derived from neonatal rats. Voltage-
activated Ca2+, K+ and Na+ currents were elicited in the whole-cell conﬁguration
of the patch clamp technique, and were isolated using speciﬁc internal solutions.
Externally applied MPTP and MPP+ showed opposing effects on the electrical
properties of DRG neurons and only MPP+ showed signiﬁcant inhibitory effects.
Voltage-activated Ca2+ currents were dose- and time-dependently inhibited by
MPP+, while higher doses of MPP+ evoked an inhibitory effect on the voltage-
gated K+ currents. The voltage-activated Na+ currents remained unaltered. The
present study indicates that, MPP+ reduces currents through voltage-gated Ca2+
channels, and this may have direct bearing on the neurotoxicity caused by this
potent neurotoxin.
Keywords: calcium channel, dorsal root ganglion cells, methylphenyl tetrahydro-
pyridine (MPTP), Parkinson’s disease, patchclamp.
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Effect of acetylcholinesterase inhibitors in
streptozotocin-induced Alzheimer’s disease in rats
M. Hina and K. P. Mohanakumar
Division of Neurosciences, Indian Institute of Chemical Biology,
Calcutta, India
Therapy of Alzheimer’s disease (AD) by acetylcholinesterase inhibitors has
brought in a host of problems because of its severe side effects including tremor.
Though anticholinesterases cause an increase in the level of acetylcholine in the
brain, other classes of neurotransmitters may also be affected. To understand the
extent of involvement of biogenic amine neurotransmitters in the actions of
anticholinestarase in AD, we investigated the effects of physostigmine and tacrine
in an animal model of the disease. Rats were administered intracerebroventricu-
larly with streptozotocin (STZ), and treated with physostigmine or tacrine. Discrete
brain regions such as nucleus caudate putamen (NCP) and hippocampus were
dissected and analyzed for the biogenic amines employing HPLC-electrochem-
istry. Cognitive functions were assessed using a Plus-maze apparatus. Cholinest-
erase activity increased signiﬁcantly in striatum where as reduced in HP on 21st
day following STZ administration. While the cholinesterase inhibitor caused
severe inhibition of acetylcholinesterase in the striatum, heightened serotonin
levels were observed in the striatum and hippocampus. Initially after the STZ
injection, DA and 5-HT levels are reduced signiﬁcantly on day 14, in NCP and HP.
DA level was increased signiﬁcantly in both NCP and HP along with 5-HT in NCP
alone, on 21day following icv injection of STZ. Norepinephrine was unaffected.
Treatment with cholinesterase inhibitor in the STZ pretreated animals, compen-
sates the STZ-induced changes in DA and 5-HT in NCP as well as HP. The
behavioral and biochemical observations from the present study indicate the
neurochemical basis of the side effects (eg. tremor, hallucination, etc.) observed
following anticholinesterase therapy in AD.
Keywords: acetylcholinesterase, Alzheimer’s disease, hippocampus, streptozoto-
cin, striatum.
P09-54
C-terminal cytoplasmic fragments of APP induce
neurotoxicities through the transcriptional modulated
mechanism
K.-A. Chang, J.-W. Ha, H.-S. Kim and Y.-H. Suh
Department of Pharmacology, Nat’l Creative Research Initiative
Centre for AD and Neuroscience Research Institute, MRC, College
of Medicine, Seoul Nat’l University, Seoul, Korea
Amyloid b peptide (Ab) is a metabolic product of the amyloid precursor protein
(APP) that accumulates in neuritic plaques in Alzheimer’s disease (AD). However,
although it is believed that Ab 40 and Ab 42 form is pathogenic, intramembrane
cleavage of APP generates both Ab and C-terminal cytoplasmic fragment. An
earlier report suggests that Ab may not be the sole active component involved in
the pathogenesis of AD. Therefore, other cleavage products of APP may contribute
to the neurodegenerative process and their potentialities need to be explored. There
are recent reports that a shorter 50 amino acid C-terminal fragment (CTF50) is
generated from a second transmembrane cleavage site in APP as well as CTF99,
CTF59(CTF57) and CTF31. However, it is unclear whether CTF50 as well as
CTF99 and how CTF50 or CTF99 could contribute to neurodegeneration. In the
present study, we have found that the expression of CTF50 and CTF99 lead to
apoptosis by caspase-3 activation in neuronal cells unrelated with nucleus
signaling. In addition, expression of CTF50 and CTF99 in neuronal cells induce
the up-regulation of GSK-3b gene in the nucleus through interaction with Fe65
and CP2/LSF/LBP1 transcription factor, whereas the deletion of YENPTY domain
does not. This occurred with an increase in the active form of GSK-3b,
accompanied by the induction of tau phosphorylation leading to apoptosis. From
these results, we suggest tnat CTF50 and CTF99 might contribute to the neuronal
degeneration in AD through not only mitochondrial dysfunction but also the
nucleus signaling involved in transcription of genes including GSK-3b.
Keywords: Alzheimer’s disease, C-terminal fragment of amyloid precursor
protein, Fe65, glycogen synthase kinase 3b.
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A novel protein interacts with a-synuclein
Q. L. Ma,* B. Chen,* and K. Ue´da*,
*Department of Neurology, Xuanwu Hospital of Capital University
of Medical Sciences, Beijing, China; Department of
Neurochemistry, Tokyo Institute of Psychiatry, Tokyo, Japan
Objectives: a-synuclein, a pre-synaptic molecule, was originally identiﬁed in
Alzheimer’s disease amyloid and named non-Ab component precursor (NACP).
Later, two missense mutations in the a-synuclein gene had been identiﬁed in
autosomal dominant familial Parkinson’s disease (PD). Increasing evidence
indicated that a-synuclein was involved in the pathogenesis of several neurode-
generative disorders, including Parkinson’s disease (PD), Lewy body disease
(LBD) and multiple system atrophy (MSA). However the mechanisms underlying
a-synuclein involvement are unclear. To investigate the potential factors that may
act as protein-interaction partners of a-synuclein, we carried out studies to identify
proteins that interact with a-synuclein.
Methods: Afﬁnity column chromatography was used to isolate the novel proteins
that may interact with a-synuclein from human brain tissues. The interaction was
conﬁrmed by immunohistochemistry, immunoblotting and immunocytochemistry
of cultured neurons.
Results: A novel protein that interacts with a-synuclein was identiﬁed.
Conclusion: Our results appear to suggest that a novel protein that may interact
with a-synuclein was identiﬁed and it may play an important role in the
pathogenesis of neurodegenerative disorders.
Keywords: a-synuclein, neurodegenerative disorders.
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Effect of medicinal herbs on acetylcholinesterase
inhibition and tau phosphorylation
M. T. W. Ho, D. C. C. Wan and P. C. Shaw
The Chinese University of Hong Kong, Hong Kong, Hong Kong
We have examined three extracts from Chinese medicinal materials for
inhibitory activity against acetylcholinesterase (AChE). AChE activity was
determined by the colorimetric Ellman assay. Both the aqueous and ethanol
extracts were tested for AChE inhihitory activity. The aqueous extract
(10 mg/mL) of Radix Paeoniae Rubra (Chi Shao) showed modest 55%
inhibition against human AChE while that of Radix Paeoniae Lactiﬂorae
(Bai Shao) gave 35% inhibition at the same concentration. The ethanol
extract of Chi Shao showed mild 30% inhibition at 10 mg/mL, while Bai
Shao gave a 70% inhibition with ethanol extract at the same concentration.
Chi Shao and Bai Shao belong to the family of Ranunculaceae and
sometimes they are used interchangeably. Decoctions of Bai Shao can inhibit
inﬂammation. The extracts of Pericarpium Citri Reticulatae (Chen Pi) were
also examined and both gave a 20% increase in the AChE activity at 50 mg/
mL. The extract was found to increase tau protein phosphorylation as
detected by tau phospho-dependent antibodies. It supports the possible
linkage between AChE activity and tau phosphorylation level. Effect of Chi
Shao and Bai Shao on tau phosphorylation will also be discussed.
Keywords: acetylcholinesterase, Alzheimer’s disease, antibodies, phos-
phorylation, tau protein.
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Involvement of calcium in 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP)-induced experimental
parkinsonism
S. Samantaray and K. P. Mohanakumar
Division of Neurosciences, Indian Institute of Chemical Biology,
Calcutta, India
Parkinson’s disease, a progressive neurodegenerative disorder, involves the
selective degeneration of A9 substantia nigra neurons in the brain. In the
present study, we hypothesize that the active form of the parkinsonian toxin,
1-methyl-4-phenyl pyridinium ion (MPP+) acts as a Ca2+ channel blocker.
The study explores the Ca2+-involvement in this selective neurodegeneration
at three levels: (i) subcellular level aiming to assess the intrasynaptosomal
Ca2+ ﬂux using Fura-2AM; (ii) tissue level employing HPLC-electrochem-
istry to monitor dopamine release from striatal slices; and (iii) organism level
involving in vivo studies by pharmacologically intervening with L-type
dihydropyridine Ca2+ channel agonist, (±)-Bay K8644 and antagonist,
nicardipine. The active metabolite, MPP+ was used for in vitro and ex vivo
experiments whereas for in vivo investigations, Balb/c mice were injected
with MPTP. In vivo effects of calcium channel agonist, Bay K8644 and
antagonist, nicardipine with and without MPTP were monitored for different
parameters such as monoamine oxidase-B activity, tyrosine hydroxylation,
MPP+ formation in the striatum, levels of reduced (GSH) and oxidized
glutathione (GSSG), and striatal DA employing HPLC-electrochemistry. In
the present study we observed MPP+ causes an increase in intrasynaptosomal
Ca2+, culminating in DA release from the striatum, which is sensitive to L-
type dihydropyridine Ca2+, channel modulation. Our studies with (±)-Bay
K8644 and nicardipine afﬁrmed the involvement of L-type Ca2+ channels in
MPTP-neurotoxicity. Relevant ﬁndings from the study proved our hypothe-
sis: MPP+ being a Ca2+ channel blocker, acting at the L-type Ca2+ channels.
Keywords: Parkinson’s disease, methylphenyl tetrahydropyridine, calcium,
calcium channel, neurodegeneration.
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Serotonin 5-HT2A receptor alterations in the postmortem
neocortex of behaviorally assessed Alzheimer patients
M. K. Lai,* S. W. Tsang, M. M. Esiri, J. Keene, T. Hope,
P. T. Francis,§ P. T. Wong and C. P. Chen¶
*Department of Clinical Research, Singapore General Hospital;
Department of Pharmacology, National University of Singapore,
Singapore; Departments of Neuropathology, Psychiatry and
Ethox, IOHS, Oxford University; §Dementia Research Lab, King’s
College London, UK; ¶National Neuroscience Institute, Singapore
Levels of serotonin 5-HT2A receptors were measured by [
3H]ketanserin
binding in the postmortem frontal and temporal cortex of Alzheimer Disease
(AD) patients prospectively assessed for cognition and neuropsychiatric
behaviors, as well as matched controls. In agreement with previous studies,
5-HT2A receptor densities were reduced in both regions in AD. However,
these receptor alterations were correlated only with dementia severity, and
not with premortem behaviors such as depression, psychosis, anxiety and
aggression. This study suggests that 5-HT2A levels may be a marker of
neurodegeneration in AD but may not be directly involved in neuropsychi-
atric behaviors, in contrast to results obtained from previous retrospective
studies.
Keywords: alzheimer disease, neocortex, neuropsychiatric behavior, sero-
tonin receptors.
P09-60
L-deprenyl attenuates the rotenone-induced
dopaminergic neurotoxicity: experimental evidences in
rats
K. S. Saravanan, K. M. Sindhu and K. P. Mohanakumar
Division of Neurosciences, Indian Institute of Chemical Biology,
Calcutta, India
Parkinson disease (PD) is progressive neurological disorder because of
massive degeneration of nigrostriatal dopaminergic neurons. The pathogen-
esis of PD is unknown, but considerable evidence suggests multifactorial
factors including genetic, mitochondrial dysfunction, oxidative stress,
excitotoxicity, calcium cytotoxicity, environmental factors and apoptosis.
We investigated the role of oxidative damage produced by intranigral
infusion of a potent mitochondrial complex-I inhibitor, rotenone and studied
the neuroprotective effects with a well-known antiparkinsonian drug
L-deprenyl in rats. Unilateral stereotaxic intranigral infusion of rotenone
6 lg caused signiﬁcant decrease in dopamine levels. L-deprenyl (10 mg/kg)
treatment signiﬁcantly attenuated the DA depletion caused by rotenone.
Parallely, a signiﬁcant decrease in the concentration of GSH was also
observed in the SN was reverted by L-deprenyl treatment. L-deprenyl
signiﬁcantly attenuated the rotenone-induced decrease in tyrosine hydroxy-
lase immunoreactivity in striatum. The results suggest that L-deprenyl can
rescue the dopaminergic neurons from the rotenone mediated neurodegen-
eration in this experimental animal model.
Keywords: complex I, deprenyl, glutathione, oxidative stress, Parkinson’s
disease.
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Co-transplantation with GDNF and VMC: a better
approach in restoration of neurobehavioral function in
6-OHDA lesioned rat model of Parkinson’s disease
R. K. Chaturvedi, A. K. Agrawal, K. Seth, Y. Shukla, S. Shukla and
P. K. Seth
Developmental Toxicology Division, Industrial Toxicology Research
Centre, M. G. Marg, Lucknow, India
During neural transplantation, degeneration of transplanted VMC is very
high due to lack of trophic support and mismatch conditions. In the present
study an attempt has been made to validate the role of Glial cell line-derived
Neurotrophic Factor (GDNF) co-transplanted with fetal VMC in functional
restoration in rat model of Parkinson’s disease. A signiﬁcant restoration was
observed in amphetamine induced rotation in rats co- transplanted with
GDNF and VMC (66%, p < 0.001) as compare to VMC alone (42%).
Apomorphine induced locomotor activity was restored by 67% (p < 0.01),
38% in co-transplanted and VMC alone transplanted rats respectively. Level
of dopamine and 3,4 dihydroxy-phenyl acetic acid (DOPAC) in the striatum
were signiﬁcantly restored by 67 and 62% (p < 0.01), 42 and 33% (p < 0.05)
in co-transplanted and VMC alone transplanted rats respectively. A
signiﬁcant restoration was observed in striatum dopamine receptors by
69% in rats co-transplanted with VMC & GDNF, and 45% in those
transplanted with VMC alone. The functional viability of transplanted VMC
was conﬁrmed by tyrosine hydroxylase (TH) expression and quantiﬁcation of
TH positive cells by image analysis revealed a signiﬁcant restoration in
number of TH-positive cells as well as area of TH expression in co-
transplanted animals over VMC transplanted animals. However restoration
was more pronounced in the case of microtransplantation approach as
compared to macrotransplantation.
Keywords: amphetamine, apomrphine, GDNF, microtransplantation, Par-
kinson’s disease.
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Supplemental role of antioxidants in fetal ventral
mesencephalic cell (VMC) and olfactory ensheathing cell
transplantation (OEC)
S. Shukla, K. Agrawal, K. Seth, R. Chaturvedi and P. K. Seth
Developmental Toxicology Division, Industrial Toxicology Research
Centre, M. G. Marg, Lucknow, India
Fetal neural transplantation is one of the promising therapy in PD, but major
constraint is low survival of transplanted cells (2–5%) ﬁrst week post-
transplantation, less availability of fetal tissue and ethical issues raised due to
use of fetuses. Major factors causing low survival are apoptosis, free redical
mediated toxicity. In order to overcome free redical mediated toxicity and to
enhance the survival of transplanted cells, in the present study an attempt has
been made to co-transplant fetal VMC with OEC and antioxidants (10 mM of
glutathione and ascorbic acid) to minimize the use of fetal tissue and to
protect from oxidative stress respectively. The functional recovery was
evaluated at 4 week post transplantation by evaluating selected neurobeh-
avioral, neurochemical and immunohistochemical parameters.THE 6-
OHDA lesioned animals exhibited an increase in amphetamine
induced locomotor activity (65%) and amphetamine induced
circling behaviour (72%) and dopamine receptors (65%).The rats
receiving only OEC showed an average 23% recovery, while the
rats receiving only VMC showed an average of 42% recovery in
these parameters. The rats administered OEC+VMC showed 65%
recovery. The antioxidant supplementation to VMC + OEC further
enhanced the recovery to 71%.The results suggest that supplemen-
tation of antioxidants has beneﬁcial and additive role.
Keywords: Antioxidants, apomorphine, olfactory ensheathing cells, tyrosine
hydroxylase.
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Development of cell models over-expressed with human
amyloid precursor protein for the study of amyloid
processing and cell death
M. H. Leung,* K. W. K. Tsim and D. C. C. Wan*
*Department of Biochemistry, The Chinese University of Hong
Kong; Department of Biology, The Hong Kong University of
Science and Technology, SAR China
Human amyloid precursor protein (APP) expression, processing and
localization were studied in vitro in cell cultures. The aim was to evaluate
the impact of over-expression and accumulation of amyloid peptides on cell
death. Human amyloid precursor protein isoforms APP695 and APP770 were
cloned by RT-PCR. The full coding APP cDNAs were subcloned into
mammalian expression vector pCMV-tag1. The pCMV-tag1-APP695 was
transfected to a human neuroblastoma cell line, SH-SY5Y and a non-
neuronal cell line, HEK293. The cell line stably transfected with APP695
was generated by treatment of the transfected cells with G418 for at least
4 weeks. The accumulation of the insoluble 39-42 a.a. Ab and the C-terminal
fragments formed by aberrant APP processing, particularly by b-secretases
was analyzed by Western blots and ELISA. The transfected cells were also
tested for evidence of apoptosis and neuronal cell death. Other than
secretases, recent data suggest that a brain-speciﬁc trypsin-like enzyme
neurosin (zyme) might play a role in the processing/degradation of APP. This
enzyme was also cloned and characterized to determine its role in APP
processing using the established cell models.
Keywords: Alzheimer’s disease, amyloid, apoptosis, caspase, immunoblot-
ting.
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Attenuation of stimulated calcium responses of PC12
cells by amyloid b peptide
P.-C. Wu,* H.-J. Tsay,* L.-S. Kao, D.-M. Yang and Y.-J. Sung§
*Institute of Neuroscience. Faculty of Life Sciences, National
Yang-Ming University, Taipei, Taiwan, ROC; Department of
Medical Research and Education, Taipei Veterans General
Hospital; §Institute of Anatomy and Cell Biology, National Yang-
Ming University, Taipei, Taiwan, ROC
Amyloid peptide (Ab) forms senile plaques in the brain of patients with
Alzheimer’s disease (AD). Ab has been shown to be neurotoxic to cells, but
the exact mechanisms are unknown. One possible mechanism of Ab toxicity
involves a calcium dysregulation accompanied with enhanced vulnerability
to excitotoxic stimuli. This study examined the effects of Ab on the calcium
signaling using PC12 cell as a model system. Both high potassium (K) and
ATP stimulations rapidly elevated cytosolic calcium and followed by a
gradual decrease to the resting level in control PC12 cells. Prolonged
exposure to Ab decreased the amplitude of the high K- or ATP-induced
cytosolic calcium increase and the high K-induced mitochondrial calcium
increase. However, Ab did not affect the basal calcium level in the cytosol
and mitochondria. Ab treatment had no effect on the calcium storage capacity
of? mitochondria and ER, estimated by carbonyl cyanide m-clorophenylhy-
drazone (CCCP)- and thapsigargin (TG)-induced calcium spike. In the
presence of CCCP or TG, similar attenuation of high K-induced elevation of
cytosolic calcium was observed. The results indicate that the attenuation of
high K- or ATP-induced calcium responses of PC12 cells by prolonged
exposure to Ab is because of a direct effect on the channels or receptor in the
plasma membrane rather than on the mitochondria or ER.
Keywords: amyloid peptide, carbonyl cyanide m-clorophenylhydrazone,
PC12, thapsigargin.
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NMDA receptor dysfunction in Alzheimer’s disease
M. R. Hynd, H. L. Scott and P. R. Dodd
Department of Biochemistry, University of Queensland, Brisbane,
Australia
The inherent neurotoxic potential of the endogenous excitatory amino acid
glutamate, may be causally related to the pathogenesis of AD neurodegen-
eration. Neuronal excitotoxicity is conceivably mediated by the N-methyl-D-
aspartate-(NMDA)-Ca2+-ionotropic receptor. NMDA receptors exist as
multimeric complexes comprising proteins from two families – NR1 and
NR2(A-D). The polyamines, spermine and spermidine bind to, and modulate
NMDA receptor efﬁcacy via interaction with exon 5, an alternatively-spliced,
21 amino acid, N-terminal cassette. AD-associated cognitive impairment
may therefore occur via subunit-speciﬁc NMDA receptor dysfunction
effecting regional selectivity of neuronal degradation. Total RNA was
prepared from pathologically spared and susceptible regions from AD cases
and matched controls. Quantitation was performed using standard curve
methodology in which a known amount of a synthetic ribonucleic acid
competitor deletion construct was co-ampliﬁed against total RNA. Expres-
sion proﬁle analysis of two NR1 mRNA subsets has revealed signiﬁcant
differences in NR11XX mRNA levels in cingulate gyrus, p < 0.01; superior
temporal cortex, p < 0.01 and hippocampus, p ¼ 0.05. Differential age-
dependent expression for NMDA isoforms was found in pathologically
affected regions in AD. Proportionate NR11XX expression in AD cingulate
gyrus and temporal cortex was lower at younger ages in AD cases and
increased with age. Quantitation of individual NR1 splice-variants revealed a
nonselective reduction of all variants containing exon 5. mRNA levels for
NR2A and NR2B were similarly reduced in AD susceptible areas, p < 0.05.
Variations in endogenous NR1 and NR2 mRNA levels suggest a relationship
between the NMDA receptor, mediation of excitotoxic neuronal degeneration
and AD pathogenesis.
Keywords: Alzheimer’s disease, excitatory amino acid receptors, mRNA,
neurodegeneration, NMDA.
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Time-dependent increase in parkin expression during
unfolded protein stress in cultured astrocytes
M. C. Lau,* H. L. Choi,* P. H. Jensen and A. Stadlin*
*Department of Anatomy, Chinese University of Hong Kong, Hong
Kong; Department of Medical Biochemistry, University of Aarhus,
Aarhus, Denmark
Dysfunction of the E3 ubiquitin ligase parkin because of mutations is the
cause autosomal recessive juvenile parkinsonism. Parkin protects cells
against the toxicity of unfolded proteins and unfolded protein stress has been
postulated to be one of the mechanisms underlying nigral degeneration in
Parkinson’s disease. It was shown recently that unfolded protein stress (UPS)
elicited a selective increase in astrocytic parkin expression not shown in
neurons in the hippocampus. The current study used 10 lg/ml tunicamycin
to induce unfolded protein stress in astrocytes cultured from rat hippocam-
pus, cortex, striatum and mesencephalon to further explore the role of
astrocytes upon UPS. At 3, 6, 12 and 24 h after tunicamycin treatment, cells
were extracted and the protein expressions of parkin, a-synuclein and BiP
(ER) were examined by western blot analysis. Results showed that at 12 and
24 h after treatment, there is an increased expression of ER protein BiP when
compared with controls. Concomitantly, there is an increased expression of
parkin protein. There is no change in the level of a-synuclein expression at
all time points studied. This phenomenon is ubiquitous to astrocytes from all
regions studied. This study demonstrates that increased parkin expression is
part of a global astrocytic response to unfolded protein stress and indicates
that parkin dysfunction may play a wider in neurodegenerative disorders.
Keywords: astrocytes, cell culture, Parkinson’s disease, ubiquitin.
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C-terminal fragments of amyloid precursor protein exert
neurotoxicity by transcription dependent mechanism
J.-W. Ha, N. Kim, H.-S. Kim, K.-A. Chang and Y.-H. Suh
National Creative Research Initiative Centre For Alzheimer’s
Dementia, Department of Pharmacology, College of Medicine,
Seoul National University, Seoul, Korea
Amyloid precursor protein (APP) is cleaved in its transmembrane region by
c-secretase. b- and c-cleavage of APP generates the extracellular amyloid
b-peptide (A?), the main component of Alzheimer’s disease (AD) senile
plaques, and releases a free carboxyl terminal intracellular fragment (APP-
CT). APP-CTF (C-terminal fragment of amyloid precursor protein) is
recently suggested to form a complex with Fe65 and the histone
acetyltransferase Tip60 and may affect gene transcription. In this study, we
investigated the effect of C-terminal fragment of amyloid precursor protein
on histone acetyltransferase and cytotoxicity. The cytoplasmic tail of APP
binds to Fe65 and histone acetyltransferase to increase acetylated histone and
also increases cytotoxicity. Moreover, the levels of acetylated histone and
cytotoxicity are signiﬁcantly increased by the histone deacetylase inhibitor
sodium butyrate. Dexamethasone, a possible candidate for histone acetyl-
transferase inhibitor, shows no inhibitory effect on the activity of histone
acetyltransferase and cytotoxicity.
Keywords: Alzheimer’s disease, cytotoxicity, dementia, neurotoxins.
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Minocycline exerts protective effects on the
neurotoxocity induced by Ab and various C-terminal
fragments of APP
Y. Choi, E.-M. Kim, C. H. Park, H.-S. Kim, K.-Y. Shin and
Y.-H. Suh
Department of Pharmacology, College of Medicine, National
Creative Research Initiative Center for Alzheimer’s Dementia and
Neuroscience Research Institute, MRC, Seoul National University,
Seoul, South Korea
Alzheimer’s disease (AD) is a neurodegenerative disorder neuropathologi-
cally characterized by the presence of neuritic plaques containing amyloid
ﬁbrils and neuroﬁbrillary tangles whose main component is paired helical
ﬁlament composed of hyperphosphorylated tau. There are numerous lines of
evidence that some of the neurotoxicity associated with AD is because of
proteolytic fragments of amyloid precursor protein (APP) including amyloid
beta peptide (Ab), which is the main component of neuritic plaques.
Minocycline is a second-generation tetracycline that effectively crosses the
blood–brain barrier. It has remarkable neuroprotective qualities in models of
cerebral ischaemia, traumatic brain injury, and Huntington’s and Parkinson’s
disease. However, there is no evidence about neuroprotective effects of
minocycline on AD. In this study, we demonstrate that minocycline exerts
protective effects on the neurotoxicity induced by Ab and various C-terminal
fragments of APP through inhibition of cytochrome c release and caspase-3
activation. And also, we have investigated the effects of minocycline on the
learning and memory impairment and reduction of ACh levels and PDH
activities in cerebral cortex and hippocampus induced by injection of C-
terminal fragments of APP in rats.
Keywords: Alzheimer’s disease, amyloid, minocyclin.
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a-Synuclein induced-apoptosis in human peripheral
blood mononular cells
C. J. Heo, S.-H. Kim, I.-P. Sun and Y.-H. Suh
National Creative Research Initiative Centre for Alzheimer’s
Dementia, Seoul National University, Seoul, South Korea
Human a-synuclein is a 140 amino acid protein with little or no secondary
structure. The a-synuclein is expressed at high levels in the brain and
enriched in neural synaptic terminals but its physiological function remains
largely unknown. More recently, a-synuclein has been shown to be one of the
principal componets of Lewy bodies, neuronal inclusions that are found in
diverse human neurodegenrerative disorder including the Lewy body variant
of Alzeheimer’s disease, diffuse Lewy body disease, Parkinson’s disease,
multiple system atrophy. Therefore, a-synuclein and its abnormal protein
aggregation have been thought to play a role in the pathogenesis of these
neurodegenerative diseases known as a-synucleinopathies. In order to
understand their etiology and pathogenesis, it is crucial to identify the
normal function of a-synuclein. It was previously reported that the splicing
variant of a-synuclein is expressed in heart, skeletal muscle, and pancreas. In
our study, we identiﬁed the expression in spleen and conﬁrmed the
expression of a-synuclein in isolated human PBMC. The physiological role
in lymphocytes showed induction of apoptosis with Caspase-8 and Caspase-9
activation. And also they showed enhanced expression of inﬂammatory
cytokines, like TNF-a and IL-6. This result suggest that the accumulated a-
synuclein might be involved in regulation of cell viability by the interaction
with proteins such as PKC, ERK, or BAD.
Keywords: apoptosis, caspase, lymphocyte, neurodegeneration, Parkinson’s
disease.
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Neurotoxicity and nuclear locolization of APLP2-C-
terminal fragments
Y.-J. Xu, K.-A. Chang, H.-S. Kim, E.-M. Kim, C.-H. Park,
E.-A. Yuh, Y.-H. Suh
Seoul National University, Medicine, Pharmacology, National
Creative Research Initiative Center for Alzheimer’s Dementia,
Seoul, Korea
b-Amyloid Precursor Like Protein-1 and -2 (APLP1 & APLP2) are processed
by the r-secretase and can generate carboxyterminal fragments, such as
CT57-59. CT50 and CT31 which generated by ?-secretase and caspase-3,
respectively. All processing is similar to what has been reported for AID
(APP intracellular Domain). In the present study, we investigated the
neurotoxicity and nuclear localization of APLP2-CTFs. Transfection of PC12
cells, rat primary cultured cortical neurons and HEK293cells with APLP2-
CT57, CT50, CT31 can induce apoptotic cell death after 48 h; and increase
the release of cytochrome c and activate caspase-3 in HEK293 cells. All three
CTFs translocate to the nucleus, forming ternary complex with Fe65 & CP2/
LSF/LBP1 in the nucleus, and then increase the GSK-3b mRNA and protein
levels, inducting of tau phospholation, leading to apoptosis. These results
indicate that APLP2-CTFs might contribute to the neuronal death in AD.
Keywords: APLP2-CTFs, Fe65, GSK-3beta, neurotoxicity, nuclear locoliza-
tion.
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Effects of an enriched environment on the Alzheimer
disease tg2576 transgenic mice
P. E. Vivas-Mejı´a, J. Felix and S. Pen˜a de Ortiz
University of Puerto Rico, Rio Piedras Campus, Puerto Rico
Recently it has been hypothesized that the level of education and social
stimuli that promote positive behavioral and mental activities can delay the
onset of Alzheimer Disease (AD). Although, there is not yet a perfect
transgenic mouse that shows all of the neuropathological features AD, the use
of the AD-transgenic mice has been useful not only to understand many of
the molecular and structural bases of AD but also to understand the learning
and memory processes. APP695 SWE mice expressing transgenic human
APP with the two point Swedish mutations show age-dependent impair-
ments and many pathological features typical of AD. We used the Tg2576
mice (Tg) to test the hypothesis that an Enrichment Environmental can delay
the onset of the pathological features of AD in these transgenic animals.
Twelve weeks old, 26 animals (14 wild-type littermates and 12 Tg) were
used initially in this study. Eight wild-type littermates and six wild-type
littermates constitute the enrich group (EG) and eight wild-type littermates
and six Tg were kept in standard cages and constitute the control (CG). All
groups of animals are subjected to behavioral tests before and after several
periods of stimulation in Enriched Environments. So far we have found that
at 12 weeks of age and prior to stimulation Tg mice are not different than
wild types in place recognition memory task. On the contrary, Tg seems to be
impaired in object recognition memory compared with wild types. Ongoing
studies will examine the effect of stimulation on hippocampus-dependent and
independent behavioral tasks. In addition, we will investigate the underlying
differences in pathology and expression of molecular markers between the
experimental groups.
Keywords: Alzheimer disease, enrichment environmental, Tg2576.
Acknowledgements: NIH/NCRR/COBRE programs sponsor this work.
P09-72
Novel cognitive improving and neuroprotective activities
of Polygala tenuifolia willdenow extract, BT-11
S.-M. Ahn, C. H. Park, S. H. Choi, J.-W. Koo, J.-H. Seo, H.-S. Kim,
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Department of Pharmacology, College of Medicine, National
Creative Research Initiative Center for Alzheimer’s Dementia and
Neuroscience Research Institute, MRC, Seoul National University,
Seoul, Korea
We performed this study to search a new active constituent that had cognitive
enhancing activity and low side effects from natural source. We found that
the extract of dried root of Polygala tenuifolia Willdenow (BT-11, 10 mg/kg,
i.p.) could signiﬁcantly reverse scopolamine-induced cognitive impairments
in rat, using a passive avoidance and a water maze test. We also investigated
the effects of BT-11 on the neurotoxicities induced by glutamate (Glu) and
toxic metabolites of amyloid precursor protein (APP) such as amyloid protein
(A and C-terminal fragment of APP (CT) in primary cultured neurons of rat.
The pretreatment of BT-11 (0.5, 3, 5 g/mL) signiﬁcantly reduced cell death
induced by Glu (1 mM), A (10), and CT105 (10 M) in a dose-dependent
manner. In addition, BT-11 inhibited acetylcholinesterase (AChE) activity in
a dose-dependent and noncompetitive manner (IC50 value; 263.7 g/mL). Our
novel ﬁndings suggest the possibility that this extract may have some
protective effects on neuronal death and cognitive impairments in Alzhei-
mer’s disease (AD) or other neurodegenerative diseases central cholinergic
dysfunction related to excitotoxicity.
Keywords: AD, APP, BT-11, CT, neurodegeneration.
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The role of a-synuclein in the BCL2 family expression
and PI3-AKT kinase pathway
J.-H. Seo, J.-C. Rah, S. H. Choi, J. K. Shin, H.-S. Kim, C. H. Park,
S. Kim and Y.-H. Suh
Department of Pharmacology, National Creative Research Initiative
Center for Alzheimer’s Dementia and Neuroscience Research
Institute, MRC, Seoul National University, Seoul, South Korea
a-Synuclein (SN) is a ubiquitous protein that is highly abundant in
the brain and is implicated to play a central role in the pathogenesis
of many neurodegenerative diseases including Alzheimer’s and
Parkinson’s disease. Nevertheless this protein is so crucial in the
function of the brain and in human brain diseases, the physiological
functions and the molecular role of SN in the pathogenesis of
neurodegeneration are still unknown. There are many controversies
and doubts in its normal physiological functions in the nervous
system and its precise roles in the cell death. Here, we report that
SN has neuron speciﬁc dual neuroprotective and neurotoxic effects
depending on its concentration. In the nanomolar levels, SN
protected neurons against serum-deprivation, oxidative stress and
excitotoxicity through the PI3-Akt signaling pathway. In contrast,
both low micromolar of SN and overexpressed SN induced
cytotoxicity, which might be mediated by the decreased bcl-2
expression and increased bax expression subsequently followed by
cytochrome c release and caspase activation, and by microglia-
mediated inﬂammatory response via the NF-kB and MAPK
pathways.
Keywords: Alzheimer’s disease, cell death, neurodegeneration,
Parkinson’s disease, signal transduction.
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